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Enterococcus faecalis has recently emerged as one of the leading causes of nosocomial infections. 
The ability to tolerate a variety of antibiotics and environmental stresses (biotic and abiotic) 
combined with a plethora of host adaptation strategies allows this bacterium to transition from its 
sessile state as gut commensal into an opportunistic pathogen that can colonize multiple niches in 
a host to cause persistent infections. Pheromone-mediated conjugation facilitates E. faecalis in 
acquiring a variety of antibiotic resistance genes and virulence factors which are often encoded by 
the pheromone-responsive plasmid that undergoes cell to cell transfer during conjugation. 
Although a lot is known about the mechanisms by which pheromones regulate gene expression in 
these systems, the transport of these pheromones (export and import) across the cell membrane is 
poorly understood. In the current study we have identified the ABC transporter (PptAB) that is 
required for the secretion of these peptide sex pheromones. Using 3 distinct pheromone-responsive 
plasmids systems we demonstrated that the deletion of this transporter (pptAB) resulted in a severe 
conjugation defect. We also identified a second oligopeptide permease (Opp) that is involved in 
the import of these secreted peptide sex pheromones into the cell.  Deletion of the genes encoding 
these peptide transporters (pptAB, opp1 and opp2) resulted in a severe biofilm defect suggestive 
of a role played by these peptide pheromones in the development of these surface adherent 
structured communities.    
We also identified the additional roles played by the membrane protein Eep in the stress adaptation 
pathways of E. faecalis. Eep was originally described as a protein that was involved in the 
processing of lipoprotein derived peptide sex pheromones. We showed that Eep is the site-2 
protease that is involved in the regulated intramembrane proteolysis of an anti-sigma factor called 
RsiV which in turn results in the activation of an extracytoplasmic function sigma factor called 
SigV that confers high level resistance to lysozyme. We also showed that the deletion of eep 
increases the susceptibility of E. faecalis towards high temperature, low pH and ethanol stresses 
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Thiercelin (1899) identified enterococci as a gram-positive intestinal commensal capable of 
forming chains. Enterococci were originally classified under the genus Streptococcus, however in 
1984 it was recognized as a separate genus due to its distinct differences from the streptococci (1). 
Over the last two decades, enterococci have emerged among the vanguard of antibiotic resistant 
strains due to extensive acquisition of mobile genetic elements and this coupled with the extended 
use of broad-spectrum antibiotics in clinical settings has allowed them to transition from gut 
commensals to leading nosocomial pathogens (2). Enterococci, currently are the second leading 
cause of nosocomial infections after Staphylococcus aureus. Based on a recent study on reported 
hospital acquired/associated infections, enterococci account for 11.6% of surgical site infection, 
18.1% of central line associated blood stream infection and 15.1% of urinary tract infections (3). 
The two prominent and clinically relevant species of this genus are Enterococcus faecalis and 
Enterococcus faecium (4). Although E. faecium is gaining a lot more notoriety in recent times due 
to its high level resistance to vancomycin, ampicillin and other last line antibiotics, most 
enterococcal infections are still caused by E. faecalis (5) (6).  
The acquisition of mobile genetic elements (~25% of the genome) has endowed the pathogenic 
lineages of enterococci with virulence traits and antibiotic resistance cassettes providing an 
advantage for these strains over the non-pathogenic isolates (7). A recent study showed that the 
presence of these mobile genetic elements correlates with the absence of clustered, regularly 
interspaced short palindromic repeats (CRISPR) system in multidrug resistance enterococci (8). 
CRISPR system provide bacteria and archaea with sequence-specific, acquired defense against 





plethora of mobile genetic elements is these pathogenic enterococci. This argument is further 
validated as the first sequenced vancomycin resistant E. faecalis strain V583, which lacks a 
functional CRISPR system (8) contains mobile genetic elements of foreign origin that endow it 
with potent infectious qualities. These foreign mobile elements include two pheromone-responsive 
plasmids pTEF1 and pTEF2 which encode for antibiotic resistance genes and virulence factors, a 
third plasmid pTEF3, a large pathogenicity island (~150 kb) (~15% of the isolates), a transposon 
harboring vancomycin resistance, three integrated plasmid remenants, seven putative prophage 
regions and 38 insertion elements (9). 
The success of enterococcal colonization depends on its ability to compete with host commensal 
flora for nutrients and survive the different stresses (host factors) experienced during host 
colonization (10). Hospital lineages often have to confront and survive a multitude of antibiotics 
stresses to establish persistent infections (10). An arsenal of strategies are employed by enterococci 
to adapt to these host niches and establish successful infections amongst which biofilms have been 
shown to be an important lifestyle of enterococci in a host (10). Biofilms are complex three 
dimensional multicellular units wherein the bacteria are encapsulated in a well hydrated exo-
polymer matrix composed of polysaccharides, proteins and nucleic acids from dead cells and 
provide protection against host immune components and antibiotic therapy (11). Enterococci are 
also innately resistant to a growing number of antibiotics and exhibit high level resistance to host 
derived factors like lysozyme, bile and other antimicrobial proteins (2). The pheromone-responsive 
plasmids encode for antibiotic resistance and virulence factors such as aggregation substance and 
cytolysin which have been shown to enhance the pathogenicity of these bacteria and their ability 





dissertation, proteins involved pheromone-mediated cell signaling and gene regulation events in 
E. faecalis and other closely related gram-positive bacteria will be discussed along with how E. 
faecalis responds to lysozyme and other relevant stresses. 
 
CELL-CELL COMMUNICATION IN Enterococcus faecalis: 
The ability of bacteria to communicate to each other via secreted signaling molecules is an 
important aspect of microbiology. Several multicellular events like biofilm formation, light 
production, competence and other development processes are coordinated by these cell-cell 
communication events (13-15). Quorum sensing is a type of cell signaling wherein the bacterial 
population is sensed with the help of signaling molecules. In gram-negatives these are usually 
homoserine lactones and in gram-positives these are peptides. Enterococci communicate to each 
other via two distinct cell signaling mechanisms: 
i) Gelatinase Biosynthesis Activating Pheromone (GBAP) Signaling 
ii) Lipoprotein Derived Peptide Pheromone Signaling 
GBAP Signaling: 
A number of studies have described the critical role played by the fsr operon in regulating biofilm 
formation in Enterococcus faecalis (16). The fsr locus is analogous to the agr quorum sensing 
system in Staphylococcus aureus with respect to organization and function (17, 18). It comprises  
four genes: fsrA, fsrB, fsrD and fsrC. FsrC and FsrA are part of a bacterial two component system 
where FsrC is a membrane localized histidine kinase and FsrA is the cognate cytoplasmic response 





GBAP, that is processed and secreted outside the cell with the help of the membrane protein, FsrB 
(19, 20). Once a concentration threshold of GBAP is reached outside the cell, it then binds to the 
FsrC histidine kinase which in turn activates the response regulator, FsrA (19). Once activated, 
FsrA differentially regulates the expression of ~300 genes involved in metabolism, virulence and 
other regulatory cascades (21, 22). With respect to biofilm formation, Fsr system regulates the 
expression of two secreted proteases (GelE and SprE). GelE has been shown to be an important 
player in enterococcal biofilm development and has also been shown to be important for E. faecalis 
pathogenesis in multiple animal studies (23, 24). Although SprE has been shown to be an important 
player in the fratricide model of biofilm development (25, 26) not much is known about the 
potential roles it could be playing in enterococcal pathogenesis and deducing these is one of the 
current focuses of ongoing studies in the laboratory. 
 
Lipoprotein Derived Peptide Pheromone Signaling: 
Originally described by Dunny et al. in 1978, peptide pheromone signaling is a well characterized 
cell signaling phenomenon that occurs in E. faecalis (27). These heptapeptide or octapeptide 
signaling molecules are usually derived from processing of lipoproteins (28) and serve as signaling 
molecules to mediate transfer of unique plasmids called pheromone-responsive plasmids (29). 
Lipoprotein precursors of peptide pheromones are usually encoded in the chromosome and the 
function of most of these lipoproteins are hitherto unknown (28). A simple diagram to illustrate 







Figure 1-1: Pheromone-mediated conjugation. 
Recipient cells that lack pheromone-responsive plasmids secrete these peptide sex pheromones 
which are usually hydrophobic in nature. Donor cells that harbor these pheromone-responsive 
plasmids import these peptides via a dedicated oligopeptide permease complex. This peptide elicits 
a response in the donor that results in the expression of the aggregation substance, a large 
membrane anchored protein that results in the aggregation of donor and recipient cells. Other 
pheromone-responsive plasmid encoded genes aid in the replication and transfer of a copy of this 
plasmid to the recipient (12). Pheromone-mediated conjugation is a high frequency DNA transfer 
event, meaning that in a span of 3-4 hrs most recipients that lack plasmids acquire these plasmids. 
These plasmids usually encode for antibiotic resistance genes and endow the cells with a plethora 





regulatory cascades control the production of pheromones in E. faecalis and these pheromones in 
turn regulate the gene expression of the donor cells to enable the transfer of a copy of this 
pheromone-responsive plasmid to the recipient. In other gram-positives, peptide pheromones 
regulate the expression of genes involved biofilm formation, competence, sporulation and 
virulence (30). Peptide pheromone-mediated regulation of these aforementioned processes will be 
discussed in detail in the subsequent sections of this introduction. 
 
PEPTIDE PHEROMONE SIGNALING: 
Recent years have seen a dramatic increase in the number of studies that describe peptide 
pheromone-mediated signaling and gene regulation in gram-positives. Although all of the cell 
signaling peptides in gram-positives are ribosomally synthesized, the mechanism by which they 
regulate gene expression, their processing and secretion vary widely. Figure 1-2 depicts the 
conventional peptide signaling systems in gram-positives. Gram-positive pheromones are often 
produced from precursors which are processed by multiple proteins and ultimately get secreted out 
of the producer cells (30). Once in the external environment, these pheromones exert their effects 
on neighboring cells either by: 
i) Directly getting imported into the cell and binding to a transcriptional regulator to 
regulate gene expression. 
ii) Interacting with a surface exposed sensor histidine kinase which in turn activates 






                                      
Figure 1-2: Pheromone signaling in gram-positives. 
Several well characterized proteins and their cognate peptide pheromones regulated a variety of 
important cell functions in gram-positives including biofilm formation, competence and virulence 
gene expression. The Agr system of Staphylococcus aureus, The Fsr system of Enterococcus 
faecalis and the Com system of Streptococcus pneumoniae possess two component system that 
sense the presence of the cognate cyclic peptide pheromone via a sensor histidine kinase and 
regulates gene expression via a response regulator (RR) (30). The RNPP protein family (Rap, Npr, 
PlcR and PrgX) alter gene expression after binding to their cognate linear peptide pheromone that 
get processed and re imported into the cells via a dedicated oligopeptide permease complex. RNPP 





involved in protein-protein interactions (31, 32). These proteins and their regulatory functions 
along with the peptides they interact with are listed in Table 1-1. For the purposes of my 
dissertation, the subsequent sections of this introduction will focus on peptides pheromones in 
gram-positives that interact with RNPP family proteins to exert their gene regulatory effects in 
these bacteria. 
 
Table 1-1: Pheromone-mediated gene regulation in gram-positives. 
 
Protein Cognate peptides Function Reference 




Auto Inducing Peptide (AIP) 
 
Regulation of exotoxin production, 

















Activating Peptide (GBAP) 
 
Biofilm formation, exoprotease 



























PapR Regulation of phospholipaseC, 















Short Hydrophobic Peptide 
(SHP) 
 
Biofilm formation, extracellular 







PhrA peptide signaling in Bacillus subtilis: 
Bacillus subtilis is a sporulating gram-positive rod shaped bacteria and is considered as the model 
Gram positive bacteria for the study of developmental gene regulation. Sporulation in B. subtilis 
is controlled by the master regulator Spo0A. Phosphorylation of Spo0A is preceded by the 
phosphorylation of Spo0F which in turn forms a part of complex phosphorelay system that governs 
sporulation. Rap phosphatases are a family of protein aspartate phosphatases that dephosphorylate 
the phosphorelay intermediates in the sporulation cascade (52). Rap proteins have been 
exhaustively studied in Bacillus subtilis, which expresses 11 chromosomal- and five plasmid-
encoded members (53). Several Rap proteins block the signaling mediated by the two-component 
system by interacting with RRs. However, two completely different ways of accomplishing this 
function have been reported for members of this family. One subset of Rap proteins, including 
RapA, RapB, RapE, RapH, and RapJ, displays phosphatase activity to their target RR, Spo0F or 
Com (54-56). The second subgroup, comprising RapC, RapF, RapG, RapH, and RapK, blocks the 
action of the target RR (Spo0F or ComA) by a direct interaction with their DNA binding domain, 
and works as an anti-activator (56-59). Interestingly, RapH possesses both activities (59). For Rap 
proteins, regulatory peptides are called Phr and their mature active form is a penta- or hexa-peptide 
generated from a ~40 amino-acid precursor by means of a post-transcriptional export-import 
process (60, 61). Phr peptides are commonly linked to their target Rap proteins in such way that 
phr genes are situated immediately downstream of the genes encoding the Rap proteins to form 
Rap-Phr signaling cassettes, which are concurrently transcribed. Eight (RapA, RapC, RapE, RapF, 
RapG, RapH, RapI, and RapK) of the 11 genome-encoded Raps in B. subtilis form rap-phr 
signaling cassettes. RapB is regulated by the RapC (PhrC) peptide, while RapD and RapJ remain 






  The first described Rap-Phr system was the RapA-PhrA system in B. subtilis. Perego and Hoch 
in 1996 showed that RapA phosphatase activity was controlled by a small 48 amino acid peptide 
called PhrA which was encoded on the same transcript as RapA phosphatase. The authors showed 
that PhrA gets secreted outside the cells and undergoes proteolytic processing and the C-terminal 
portion of PhrA which comprises of 19-amino acids then re-enters the cell via the oligopeptide 
permease complex. Upon re-entry this peptide negatively regulates the expression of rapA which 
in turn allows the phosphorelay system to phosphorylate Spo0A ultimately leading to cell 
sporulation (40). The authors used phrA deletion mutants and showed that this mutant had an 
uncontrolled rapA activity and was sporulation defecient and this defect could be complemented 
by the exogenous addition of purified PhrA peptide. The involvement of the oligopeptide permease 
complex for the transport of the PhrA peptide into the cell was confirmed by the observation that 
a opp deletion mutant was sporulation defecient and this defect could not be complemented by 
adding purified pheromone but only by mutationally inactivating rapA. Using a series of truncated 
peptides, the authors also showed that last six amino acids (NH2-Ala-Ala-Arg-Asn-Gln-Thr-OH) 
retains the same activity as that of the proteolytically processed 19-amino acid C-terminal portion 
native PhrA peptide.  
 
Stephenson et al. in 2003 showed that a single proteolytic processing event is responsible for the 
production of the active pentapeptide form of PhrA in Bacillus subtilis. They also showed that this 
processing event ocurred between residues 38-40 of the of the native PhrA peptide (63). However, 
the protease that is responsible for this cleavage event still remains to be identified since none of 





Although the strucutre of RapA remains to be elucidated, two recent studies determined the three-
dimensional structures of RapF and RapH in complex with their cognate binding partners (RRs: 
ComA and Spo0F) (55, 56). Del sol et al. in 2013 solved the structure of RapF bound to its cognate 
PhrF peptide. The authors in this study showed that 6 TPR domain helices of RapF interacts with 
the PhrF peptide resulting in a confirmation change which inactivates RapF (64). Although a lot 
is known about the gene regulatory effects exerted by Phr peptides in B. subtilis the mechanism 
by which these peptides exit the cell before reimportation by the Opp complex is still unknown. 
Chapter 2 of this dissertation will provide a possible mechanism by which this cell signaling 
peptide is exported from the cell. 
 
 
NprX peptide signaling in Bacillus cereus: 
Bacillus cereus is an oppurtunistic pathogen that causes a variety of human ailments including 
food-borne gastroenteritis and more severe infections like pneumonia and endophthalmitis (65-
67). Several virulence factors contribute to the pathogenesis of B. cereus including hemolysins and 
phospholipase C. The metalloprotease NprA of B. cereus group was recently described as a 
potential virulence factor due to its host tissue degradative properties (68). Perchat et al. in 2011 
showed that in B. anthracis, B. thuringienesis and B. cereus, NprA maps close to NprR, a predicted 
transcriptional regulator belonging to the RNPP protein family (42). The authors show that the 
levels of NprA in the supernatant are minimal when these bacteria are grown in enriched medium 
and these levels significantly go up when these bacteria are grown in sporulating media confirming 
the role played by NprA during sporulation (69). A closer look at the genetic locus of nprA revealed 





between NprX and NprR is critical for NprR to activate the gene expression of nprA. The native 
NprX peptide contains 43 amino acids and based on a series of peptide truncation expreiments the 
authors showed that the active peptide has 7 amino acids (NH2-Ser-Lys-Pro-Asp-Ile-Val-Gly-OH) 
and retains the same biological acivity of the native NprX peptide. The authors also show that this 
heptapeptide binds to NprR with high affinity with a Kd of around 50 nM  and this complex binds 
tightly to the -35 box of the nprA promoter. 
 
A recent study solved the crystal structure of NprRΔHTH (lacking the helix-turn-helix motif ) 
bound to the active NprX heptapeptide (70). NprR in its inactive form exists as a dimer. The 
binding of the NprX heptatpeptide results in the a confirmation and the dimers dimerze to form a 
tetramer which is thought to then bind to the nprA promoter region. The authors also show that the 
NprX peptide binds in a deep cleft in the middle of the TPR domain of the protein. It is speculated 
that the tetrameric active form of NprR bound to NprX binds to DNA at two distinct locations and 
this would result in DNA binding similar to the DNA binding that occurs when PrgX tetramers in 
E. faecalis bind to the DNA (71). A great degree of NprR-NprX polymorphism exists among the 
different members of the B. cereus group. As a result NprR-NprX proteins in B. cereus are 
classified into seven distinct groups and the NprR proteins in each group vary significntly from 
each other with respect to their amino acid sequence. The corresponding NprX peptide of each 
group also have distinct amino acids with the exception of Aspartic acid which is the central amino 
acid of all the NprX heptapeptides. Although a lot is known about the strucutre of NprR and its 
interaction dynamics with its cognate NprX peptide, not much is known about the genes that this 






PapR peptide signaling in Bacillus cereus: 
Transcription of a plethora of virulence factors including the transcription of the phosopholipase 
C  encoding gene plcA, in B. cereus is controlled by the master transcriptional regulator, PlcR (43). 
PlcR is a prototypic member of the RNPP family of transcriptional regulators and positively 
regulates its own expression (43). Slamti et al. in 2002 showed that the activation mechanism of 
PlcR is under the control of a small 48 amino acid peptide called PapR (44). The papR gene is part 
of the PlcR regulon and is located 70 bp downstream from plcR. The authors showed that the 
deletion of papR completely abolished the expression of plcR and this in turn resulted in severly 
reduced hemolysis and virulence.  
 
Although papR encodes for a 48-amino acid peptide, it has been shown the biological activity of 
PapR can still be retained with just the last five amino acids containing an initiator methionine 
sequence (NH2-Met-Leu-Pro-Phe-Glu-Phe-OH). Subsequent studies have confirmed this and have 
shown that PapR gets processed to its pentapeptide form which in turn binds to the PlcR 
transcriptional regulator. Pomerantsev et al. in 2009 showed that the neutral protease NprB in B. 
cereus extracellularly processes the native PapR into 5, 7, 8 and 27 amino acids residues all of 
which retain biological activity (72). Once the PapR is extracellularly processed, it gets re imported 
into the cell via the oligopeptide permease complex. Binding of PapR to the PlcR protein induces 
a confirmation change that in turn is essential for PlcR to bind to DNA and initiate transcription 
of its regulon (44). The crystal structure of the biologically active form of PlcR bound to the 
pentapeptide PapR was solved in 2007.  The 34 KDa PlcR protein has an N-terminal Helix-Turn-
Helix DNA binding domain and a C-terminal regulatory domain composed of 11 helices which in 





other through their TPR domains to form a fuctional DNA binding complex. The PapR peptide 
binds to the concave side of the TPR domains (5th and 7th helices) to functionally activate the PlcR 
dimers which inturn binds to the plcR binding box (TATGNAN4TNCATA) (73, 74). 
Although a several studies have investigated the structure of PlcR and the genes that are controlled 
by this transcriptional regulator, the mechanism by which the native PapR is exported still remains 
to be elucidated. Chapter 2 of this dissertation attempts to explain a potential mechanism by which 
the PapR peptide might be transported outside the cell. 
 
SHP peptide signaling in Streptococcus pyogenes: 
Streptococcus pyogenes which is often referred to as Group A streptococci (GAS) is a bacterial 
pathogen known to cause a wide variety of human ailments ranging from the pharyngitis to the 
very severe necrotizing fasciitis. Several virulence factors aid in the pathogenesis of S. pyogenes 
in a host and the cysteine proteinase, SpeB is one such important factor. Several studies have 
shown that SpeB is important for host colonization and virulence and about a decade ago, it was 
shown that speB gene expression is regulated by an Rgg family transcription regulator (75). 
Originally described in Streptococcus gordonii as a regulator gene of glucosyltransferases (76), 
Rgg family proteins are well conserved among the members of the genus Streptococcus and 
control a variety of cellular functions including lantibiotic bacteriocin production in Streptococcus 
mutans (77) and virulence gene expression in Streptococcus agalactiae (78). Only in recent years 
were Rgg family proteins shown to interact with short hydrophobic peptides (SHP) resulting in 





In a bioinformatics study that analyzed the intergenic regions of a few streptococcal genomes it 
was found that rgg-like genes were frequently found adjacent to small genes which were predicted 
to encode for SHPs (79). The evidence that these SHPs interact with the Rgg family proteins in S. 
pyogenes was demonstrated in a study in 2011 where the authors showed that two Rgg/SHP 
systems, Rgg2/SHP2 and Rgg3/SHP3 act as competing regulators with Rgg3 as a repressor and 
Rgg2 as an activator, both working on the promoters for the two adjacent shp genes (50). The 
interaction with SHP was critical for the functioning of both these regulators. The authors also 
showed that these peptides (SHP2 and SHP3) are processed by Eep before they exit out of the cell 
and are re-imported back into the cell via the oligopeptide permease (Opp) complex. In the absence 
of SHP3, Rgg3 acts as a repressor of gene expression and blocks the transcription of target 
promoters. The binding of SHP3 is thought induce a conformational change which displaces Rgg3 
from the operator site alleviating repression. Interestingly, this de-repression event alone is not 
enough to drive the expression of the Rgg regulon in S. pyogenes. Rgg2 interaction with its cognate 
SHP-2 peptide is critical for the activation of various target genes (50). Although the Rgg2/SHP2 
and Rgg3/SHP3 systems contributes to in-vitro biofilm formation and virulence of S. pyogenes, 
not much is known about the genes that are regulated by these proteins (50, 80). 
Amongst all the Rgg proteins of S. pyogenes, Rgg1 better known as the regulator of proteinase B 
(RopB) is the most well characterized protein. Although a lot is known about the genes that RopB 
regulates and its role in virulence (75, 81), the cognate peptide that binds to this transcriptional 
regulator is not known. RopB also does not encode any divergently transcribed short peptide 
encoding gene around its genetic locus and this has made it harder to identify the peptide that it 





reduces the levels of SpeB combined with the fact that RopB shares significant structural 
homology with PrgX and PlcR proteins would suggest that RopB is activity is dependent on the 
interaction with its cognate peptide. A recent study showed that RopB-dependent activation of 
SpeB in late exponential growth is negatively affected by a peptide originating from a protein, Vfr. 
It is possible that this peptide might indeed be required for the functioning of RopB (82). 
 
cCF10 signaling in Enterococcus faecalis: 
Enterococcus faecalis is an opportunistic pathogen found as a commensal microorganism in the 
gastro-intestinal tract of most mammals including human beings. One of the hallmarks of 
enterococcal biology is their ability to transfer genes within and between species via 
conjugative/pheromone-responsive plasmids (27, 29). Conjugation in E. faecalis is controlled by 
two counteracting pheromones where one pheromone acts as the activator of genes essential for 
conjugation while the other pheromone acts as an inhibitor that prevents self-mating and 
unnecessary mating between cells that already harbor these pheromone-responsive plasmids (12). 
The activator pheromones are usually derived from lipoprotein precursors that are chromosomally 
encoded while the inhibitor peptides are plasmid encoded. A series of proteolytic events are 
essential for the processing of the lipoprotein precursor to yield the active form of the activator 
pheromone and this cascade is depicted in Figure 1-3. 1) The lipoprotein precursors are thought to 
be secreted in Gram-positive bacteria through a Sec-dependent pathway (83). 2) It is also known 
that the prolipoprotein diacylglyceryl-transferase (Lgt) is important in lipoprotein membrane 






Figure 1-3: Pheromone production in E. faecalis. 
3) Lipoprotein signal peptidase (LspA), which is a type II signal peptidase is also important for N-
terminal processing of lipoproteins and acts after Lgt and cleaves the hydrophobic N-terminal 
tether of the lipoprotein (85). 4) An et al. showed this N-terminal tether that is released is further 
processed by the membrane embedded zinc metalloprotease, Eep which results in the production 
of active pheromone (86). Several well characterized peptide pheromones in E. faecalis are 
generated via this sequential proteolytic cleavage events and are highly hydrophobic in nature with 
a length of 7-8 amino acids. These pheromones share common aspects of signaling and examples 
include the well-studied pAD1 system and pCF10 systems (87). The pAM373 system is an 





For the purposes of my dissertation, the processing events that lead to the production of active 
cCF10 and its interaction with the RNPP family member PrgX will be discussed.  
The activator pheromone of the pheromone-responsive plasmid pCF10 is derived from the 
constitutively expressed lipoprotein CcfA whose function is still unknown (88). A schematic 




Figure 1-4: Proteolytic cleavage of CcfA to yield active cCF10 (Adapted from (88)). 
Once produced in the cytosol, CcfA is exported outside the cell via the secretory apparatus and 
anchored to the membrane via the action of Lgt. The signal peptides-II, LspA cleaves this 
lipoprotein at the conserved cysteine resulting in the release of the hydrophobic N-terminal tether. 





10 amino acid peptide is released from the cell. This is then thought to be further processed by an 
unknown exo peptidase to yeild the active cCF10 pheromone (12). Once cCF10 is secreted by 
cells, it is percieved by cells that harbor the cognate pheromone-responsive plasmid pCF10. The 
plasmid pCF10 encodes for a protein called PrgZ with homology to OppA, the substrate-binding 
subunit of the oligopeptide permease (Opp) system (89). PrgZ is thought to hijack the 
chromosomally encoded permease subunits (OppBCDF) forming a transport complex (89). 
Although it is known that the presence of PrgZ increases the donor cell response to the cCF10 
pheromone, it is not esssential for pheromone import, presumably because the chromosomally 
encoded OppA can fulfill this role (89). However OppA displays much lower affinity to cCF10 
compared to PrgZ and this is true with respect to all other pheromone-responsive plasmids systems 
wherein the plasmid encoded OppA homolog binds to the cognate pheromone with much higher 
affinity compared to the chromosomally encoded OppA. Following import, mature cCF10 binds 
to the master regulator of conjugation, PrgX, a member of the RNPP family of regulators (90). 
 
In the absence of the activating pheromone cCF10, PrgX binds to two target sites (Qa and prgX 
mRNA) in pCF10 that is located upstream of the Pq promoter (91). The protein structure of PrgX 
has been solved and this study has shown that the tetrameric form of PrgX is essential for its DNA 
binding and subsequent repression of genes encoding essential conjugation factors like the 
aggregation substance (AS) (71). The stabilization of this PrgX tetramer occurs via its interaction 
with iCF10,  antagonist of cCF10 pheromone. The inhibitor pheromone, iCF10, is encoded by the 
plasmid encoded gene prgQ and PrgQ, similar to CcfA is processed by Eep and re-imported back 
into the cell as actives iCF10 via the Opp system in conjuction with PrgZ (92). The cCF10 





for PrgX binding and it is speculated that binding of cCF10 to PrgX breaks up the tetramer by 
destabilizing the PrgX complex and the dimeric interface and this results in the alleviation of PrgX 
repression (71). 
 
PHEROMONE-RESPONSIVE PLASMIDS IN Enterococcus faecalis: 
Pheromone-responsive plasmids are a group of very large plasmids (~50 Kbp) and are 
characterized by the ability of the plasmid harboring cells (Donor cells) to form aggregates when 
mixed with plasmid free cells (Recipient cells) (27). Donor cells undergo self clumping or self 
aggregation when exogenous cognate pheromone is added to the donor cell culture or when they 
are exposed to culture supernatants containing the cognate pheromone. Once the recipient cells 
acquire the pheromone-responsive plasmids via the process of conjugation, there is a shut down 
of the cognate pheromone production; however, unrelated pheromones that are not associated with 
the pheromone resposive plasmid are still produced (29). Two distinct mechanisms are employed 
by plasmid bearing cells to prevent self aggregation i) Competitve binding by plasmid encoded 
inhibitor pheromone ii) Pheromone sequestration by TraB/PrgY (pAD1/pCF10 plasmids) proteins 
(29). 
 
The inhibitor pheromones which are also derived from protein precursors via Eep processing 
competitevely bind to TraA/PrgX (pAD1/pCF10 plasmids) proteins or their equivalents in other 
pheromone-responsive plasmids and this results in the repression of pheromone-responsive genes 
enabling the desensitization of cells to the cognate pheromones (93). It has been shown that iCF10, 
which is the inhibior pheromone encoded by pCF10 stabilizes the tetrameric form of PrgX which 





mediated conjugation (71). It is known that the amount of inhibitor pheromone produced is much 
higher than the amount of activating pheromone (80:1) and hence these plasmid bearing cells 
remain desenstized until an external source of these activating pheromones are encountered by the 
plasmid bearing cells. The second distinct mechanism preventing conjugation is mediated by the 
plasmid encoded protein TraB/PrgY  (92, 94). Although the exact mechanism by which TraB/PrgY 
dampenes the pheromone response is not known, it is known that this process is independent of 
Eep and involves the direct interaction between the activating pheromone cAD1/cCF10 with 
TraB/PrgY. Chandler et al. in 2008 showed that PrgY recognizes specific residues in cCF10 
heptapeptide and specific residues in PrgY are important for this recognition (92). It is 
hypothesized that TraB/PrgY sequesters and possibly degrades the activating pheromone with high 
affinity and this in-turn prevents the re-entry of these pheromones into the plasmid bearing cells. 
Interestingly, a recent study by Bazan et al. showed that the metazoan Wnt protease and signaling 
inhibitor TIKI shares significant sequence homology with bacterial TraB/PrgY proteins It is 
coherent to speculate that the inhibitor pheromones and TraB/PrgY family of proteins act in 
tandem to prevent self aggregation of plasmid bearing cells (29). A partial list of the well 
characterized pheromone-responsive plasmids, the cognate activating pheromones and inhibitor 
pheromones associated with them and their cellular functions are listed in Table 1-2.  Some of the 
well characterized pheromones amongst these include pAD1, pCF10 and pAM373 (12). Although 
each of these pheromone-responsive plasmids are distinctly different from each other with respect 
to the pheromones they respond to, the induction of a protein termed as “aggregation substance” 








Table 1-2: Pheromone-responsive plasmids in Enterococcus faecalis. 
 
It has been shown that aggregation substance encoded by pAD1 and pCF10 is a 1296 amino acid 
protein is anchored to the cell wall of the donor cells with the help of the sortase system and 
interacts with the lipoteichoic acid (LTA) expressed on the surface of the recipients (111, 112). It 
is interesting to note that the aggregation substance encoded by pAM373 termed as Asa373 is 
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significantly different from the AS encoded by pAD1 or pCF10. Asa373 is much smaller in size 
compared to the pAD1/pCF10 encoded AS and does not interact with the LTA of recipient cells 
(113). The interaction partner of Asa373 still remains to be elucidated. Many of the genes encoded 
by these conjugative plasmids serve as virulence factors of E. faecalis and significantly enhance 
their diesease pathogenesis in a host (29).  
 
Ike et al. in 1984 was the first to show that the cytolysin encoded by pAD1 significantly enhanced 
peritonitis in a mouse model (114). Following that report, several clinical isolates of E. faecalis 
from humans were found to harbor pAD1 or pAD1-like pheromone-responsive plasmids that 
encoded for cytolysin (115). Several follow up studies have shown that the pAD1 encoded 
cytolysin increases E. faecalis virulence in experimental models of endocarditis (116) and 
endophthalmitis (117). Another plasmid encoded gene product that has been shown to enhance 
enterococcal virulence is the aggregation substance. Presence of pheromone-responsive plasmids 
that express this aggregation substance has been shown to enhance the internalization of E. faecalis 
cells by an human epithilial cell line (118) and increse the adherence to an kidney epithileal cell 
line (119). Aggregation substance expressed by pCF10 and pAD1 have also been shown to 
improve the pathogenicity of E. faecalis in a rabbit model of experimental endocarditis (116, 120). 
It is important to note that when E. faecalis cells harboring pCF10 encounter host environmental 
factors like serum, there is in an increase in the expression of pheromone-responsive genes 
including aggregation substance. A study by Chandler et al. in 2005 showed that the inhibitor 
pheromone iCF10 gets sequestered by the host serum and this results in the resensitization of the 
pCF10 bearing donor cells to its own activating pheromone (cCF10), resulting in the expression 





rational explanation of how plasmid bearing cells express pheromones responsive genes that 
enhance virulence in a host even in the absence of an exogenous source of activating pheromone. 
 
 In addition to the significant contributions to virulence, pheromone-responsive plasmids also play 
an important role in the emergence and dissemination of antibiotic-resistant nosocomial pathogens 
(4). pCF10 was originally identified in a clinical isolate of E. faecalis that was resistant to both 
tetracycline and erythromycin (Strain SF7) from a patient in New York in 1980 (97). Interestingly 
when vancomycin resistant E. faecium emerged a decade later, a percentage of them harbored a 
conjugative vancomycin resistance plasmid called pHKK702. Interestingly some isolates of E. 
faecium harbored another distinct plasmid called pKHH703  which contained a gene that shared 
>90 % sequence similarity to PrgX of pCF10 and E. faecium strains that harbored this plasmid 
elicited an aggregation response to cCF10 (122, 123). Other sequence analysis studies have shown 
that pCF10 and pHKK703 are closely related. It is possible that pCF10 is the genetic predecessor 
of pHKK703 and that exchange of genetic information pCF10 and pHKK703 via transposition 
could have lead to the existence of this new plasmid. Another noteworthy observation is the ability 
of enterococci to exchange genetic information with S. gordonii and S. aureus by responding to 
the peptide pheromones that these species produce. Both S. gordonii and S. aureus produce 
cAM373 like pheromones that slightly differ from the enterococcal cAM373 pheromone (S. 
gordonii by three amino acids and S. aureus by one amino acid). Weigel et al. in 2003 showed that 
vancomycin resistant enterococci (VRE) can transfer this resistance (encoded by pheromone-
responsive plasmids harboring Tn1547) to S. aureus strains that produce the cAM373 like 
pheromone via the process of conjugation resulting in VRSA strains (101). Vickerman et al. in 





that produce cAM373 like pheromone (102). Few cases of VRSA have been reported in the United 
States (124) and the first reported case in Europe was only identified in 2013 (125). However, it is 
of paramount importance to prevent the dissemination of vancomycin resistance to these virulent 
pathogens since vancomycin is used as a drug of last resort to treat several gram-positive bacterial 
infections. The spread of antibiotic resistance is a dangerous problem and dissecting the 
mechanisms of transfer in E. faecalis will be essential in preventing further dissemination of 
resistance determinants to other bacterial species that are already multi-drug resistant. 
 
STRESS ADAPTATION: 
As a bacterium that can colonize the intenstine of a wide variety of fauna including humans, E. 
faecalis experiences a number of stresses in a given host environment and has evolved several 
mechanisms to survive and cause persistent infections. As a gut commensal, E. faecalis 
experiences a wide variety of stresses including oxidative stress, bile salt stress, osmotic stress and 
acid stress (low pH) to name a few (126, 127). Studies have shown that enterococci can quickly 
adapt to the aformentioned stresses when they are pre-exposed to sublethal doses of the agents that 
cause these stresses . One can speculate on the presence of transcriptional factors that efficiently 
control gene expression to ensure that the response will be rapidly induced after exposure to these 
stresses. Although E. faecalis lacks a master stress regulator like the Escherichia coli RpoS, studies 
have shown that several two-component systems in E. faecalis and other orphan regulators are 
involved in the general stress response (128). A common stress experienced by many bacteria that 
colonize the intestines in mammals is the bile salt stress. Listeria monocytogenes and E. coli have 
specific efflux pumps that are activated in the presence of bile and offer protection against this 





synthesis when grown in the presence of bile and pre-exposure to bile increases the tolerance of 
E. faecalis to other stresses including increased tolerance to daptomycin (131). In 2011, Michaux 
et al. showed that the SlyA transcriptional regulator was involved in the E. faecalis bile salt stress 
response by regulating the expression of a bile salt hydrolase (EF_3005) (132). Interestingly the 
pathogenicity island present in certain clinical isolates of E. faecalis also encodes for a second bile 
salt hydrolase (EF_0521) that is though to contribute to the resistance towards bile salts (9). A 
recent study showed that the incorporation of exogenous fatty acids contributes towards the 
resistance of E. faecalis to bile salts adding another layer of complexity to the stress response 
paradigm (131).  
 
E. faecalis can cause a variety of infections including blood stream infections and surgical site 
infections wherein it encouters a variety of stresses including oxidative stress and this occurs due 
to the production of hydrogen peroxide, hydroxyl radicals and superoxide by phagocytes present 
in blood and other neighbouring tissues (133). Several antioxidative enzymes in E. faecalis enable 
this bacterium to persist in these harsh conditions. The highly conserved mangenese containing 
superoxide dismutase (MnSOD) is encoded by the sodA gene in E. faecalis and this enzyme is 
critical for E. faecalis survival in host environments (macrophages) that generate free radicals. 
sodA deletion mutants have been shown to be attenuated in in-vivo animal models implicating its 
importance in E. faecalis pathogenesis (134). E. faecalis also encodes for catalase that degrades 
hydrogen peroxide; however, the production of active catalase protein is heme–dependent (135). 
A recent study identified several uncharacterized genes essential for the functioning of catalse in 
E. faecalis and showed that biogenesis of catalase was independent of the cytochromeABCD 





be elucidated since this bacterium does not synthesize its own heme. E. faecalis strains that harbor 
the pathogenecity island encode for a regulator known as PerR. Although the exact mechanism by 
which PerR contributes towards oxidative stress resistance is unknown, it has been demonstrated 
that PerR is important for survival inside macrophages and other phagocytes (137). 
   
Another important host immune component that E. faecalis frequently encouters during infection 
is lysozyme. This enzyme is found in a wide variety of body fluids, such as tears, breast milk, 
respiratory and saliva secretions, as well as in cells of the innate immune system, including 
neutrophils, monocytes, macrophages, and epithelial cells (138, 139). Lysozyme usually causes 
bacterial cell lysis by hydrolyzing the glycosidic linkage between N-acetylmuramic acid 
(MurNAC) and N-acetylglucosamine (GlucNAC) present in the cell wall peptidoglycan. Other 
studies have shown that lysozyme can also function as a cationic anti-microbial peptide (CAMP) 
and this leads to bacterial death likely through the destabilization of the cytoplasmic membrane 
(140, 141). Two main mechanisms are employed by bacteria to survive and persist in the presence 
of lysozyme. Both of them counteract antibacterial activity of lysozyme: i) the modification of 
different sites of the PG structure by two kinds of enzymes such as the N-acetylglucosamine 
deacetylase (PgdA) of Streptococcus pneumoniae (142), or the peptidoglycan-specific O-
acetyltransferase (OatA) of S. aureus (143) prevents the binding of lysozyme to its substrate and 
contributes to the muramidase resistance; ii) the modification of the net negative charge of the 
bacterial cell surface by adding positively charged residues (D-alanine esterification through dlt 
genes) to teichoic and lipoteichoic acids helps bacteria to avoid being killed by antimicrobial 
peptides or CAMP activity of lysozyme (144, 145). Although E. faecalis were known to be 





not known. Le Jeune et al. in 2010 showed that the extracytoplasmic function (ECF) sigma factor 
SigV, was a cruicial player in the lysozyme resistance pathway . The sigV deletion mutant 
displayed an attenuated phenotype in a murine urinary tract infection (UTI) model indicative of 
the importance of lysozyme resistance in establishing a persistent infection (146). 
 
ECF sigma factors are proteins that are activated in bacteria in response to an external 
(extracytoplasmic) signal. Some bacteria posses multiple ECF sigma factors that are activated in 
response to different stresses. The activation of ECF sigma factors is a complex process and is 
described in Figure 1-5. Under normal conditions, ECF sigma factors are sequestered to the 
membrane by a membrane spanning protein called the anti-sigma factor. The presence of the 
activating stress leads to a confirmation change in this anti-sigma factor making it susceptible to 
the action of membrane proteases (147). Two proteases are usually involved in the degradtion of 
the ant-sigma factor. The Site-1 protease cleaves first and this cleavage usually happens outside 
the intra-membrane space and a large portion of the C-terminus of the anti-sigma factor is cleaved. 
This exposes this protein to the cleavage of the Site-2 protease (148). Site-2 proteases are 
membrane embeded metallo-proteases and usually cleave the anti-sigma factor in the 
intramembrane space (149). This second cleavage event releases the ECF sigma factor into the 
cytoplasm where it is further processed by the cytoplasmic proteases (Clp proteases) and this active 
form of the ECF sigma factor regulates gene expression nesecarry for the bacterial cell to develop 
resistance towards the activating stress (148). ECF sigma factor SigV is also conserved in B. 
subtilis and Clostridium difficile and gets activated in the presence of lysoyme (150, 151). Since 
C. difficile and E. faecalis frequently colonize the intestine of the host, it is possible that SigV 






Figure 1-5: ECF sigma factor activation in bacteria. 
 
Although not much is known about the SigV regulon (genes regulated by SigV) or the proteases 
that activate SigV, it is interesting to note that in E. faecalis, pgdA (gene encoding for a 
peptidoglycan deacytelase) expression is under the direct control of SigV (146). However, the 
expression of other cell wall modifying enzymes like oatA and dlt in E. faecalis (common cell wall 
modifying enzymes that confer lysozyme resistance to other Gram positives like S. aureus and B. 
subtilis (143, 152)) is not regulated by SigV. Interestingly, Le Jeune et al. showed that when pgdA 





Taking all this account, it is possible that a novel mechanism exists and confers lysozyme 
resistance to E. faecalis. Whether this is completely under the regulation of sigV still remains to 
be elucidated. 
 
SCOPE OF THE DISSERTATION: 
In recent years, E. faecalis has emerged as one of the leading causes of nosocomial infections due 
to its ability to tolerate a variety of stresses including antibiotic stress and other host derived 
stresses. Several virulence factors have also been shown to contribute to the pathogenesis of E. 
faecalis (10). Pheromone-responsive plasmids in particular have been shown to encode for both 
antibiotic resistance genes and virulence factors and strains that harbor these plasmids display 
significantly enhanced virulence in a host (29). Although E. faecalis peptide sex pheromones and 
the mechanisms involved in the transfer of these pheromone-responsive plasmids is well 
characterized (12), very little is known about the proteins that are involved in the transport of these 
highly hydrophobic signaling molecules (89). In the second chapter of my dissertation, I have 
identified an ABC transporter that is essential for the secretion of peptide sex pheromones in E. 
faecalis. This transporter is highly conserved in other Gram positives and likely serves the same 
function in these firmicutes. In the third chapter of my disseratation, I have characterized a second 
oligopeptide permease (Opp) complex in E. faecalis and demonstrated that in the absence of the 
first complex, the second complex can serve as a backup transporter and import peptide sex 
pheromones secreted by pheromone producing cells. I have also demonstrated that the deletion of 
these transporters in tandem affects biofilm formation in E. faecalis suggestive of a possible role 
played by pheromone-mediated cell signaling in biofilm formation. In the fourth chapter of my 





Eep, in the biology of E. faecalis. Eep was orginally described as a protein that processes the N-
terminal tether of cell wall anchored lipoproteins and generates active peptide sex pheromones 
(86). Here, we show that Eep is the Site-2 protease that is essential for the activation of the ECF 
sigma factor, SigV in E. faecalis. SigV confers high levels of lysozyme resistance to E. faecalis 
and plays a role in E. faecalis pathogenesis in a murine model of urinary tract infection. Overall, 
my dissertation has identified and characterized membrane peoteins that contribute to cell 
signaling and stress adaptation in E. faecalis. In the dawn of post antibiotic era, a better 
understanding of these aformentioned membrane proteins may aid in the development of new 
therapeutics that could potentially curb antibiotic resistance resistance dissemination, stress 
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AN ABC TRANSPORTER IS REQUIRED FOR SECRETION OF PEPTIDE SEX 
PHEROMONES IN Enterococcus faecalis 
 






Enterococci are leading causes of hospital-acquired infection in the United States, and continue to 
develop resistances to new antibiotics.  Many Enterococcus faecalis isolates harbor pheromone 
responsive plasmids  that mediate horizontal transfer of even large blocks of chromosomal genes, 
resulting in hospital adapted strains with over a quarter of their genome consisting of mobile 
elements.  Pheromones to which the donor cells respond, derive from lipoprotein signal peptides. 
Using a novel bacterial killing assay dependent on the presence of sex pheromones, we screened 
transposon mutant library for functions that relate to the production and/or activity of the effector 
pheromone. Here we describe a previously uncharacterized, but well conserved ABC transporter 
that contributes to pheromone production. Using three distinct pheromone-dependent mating 
systems, we show that mutants defective in expressing this transporter display a 5-6 order of 
magnitude reduction in conjugation efficiency.  In addition, we demonstrate that the ABC 
transporter mutant displays an altered biofilm architecture, with a significant reduction in biofilm 
biomass compared to its isogenic parent, suggesting that pheromone activity also influences 
biofilm development.  The conservation of this peptide transporter across the Firmicutes suggests 
that it may also play an important role in cell-cell communication in other species within this 









Enterococcus faecalis is an opportunistic pathogen that has emerged as a leading cause of hospital-
acquired infection in the United States (1).  Enterococci exhibit resistance to many antibiotics, and 
heavily colonize patients after antibiotic therapy (2).  E. faecalis is particularly facile at exchanging 
mobile elements, having evolved a pheromone mediated conjugation system (3).  Recipient cells 
release an array of pheromones into the environment and a potential donor specifically responds 
to a unique pheromone by inducing a conjugative mating response that includes the production of 
a plasmid-encoded adhesive protein called aggregation substance that promotes effective mating 
pair formation in liquid cultures, leading to efficient plasmid transfer from donor to recipient (4-
8). Distinct pheromone responsive plasmid systems have been identified in E. faecalis (9) and are 
known to harbor traits that contribute to the severity of infection including cytolysin, aggregation 
substance and a wide variety of antibiotic resistance genes (10-12). Peptide pheromones derive 
from lipoprotein signal peptides and are generally hepta or octamer peptides comprised of 
predominantly hydrophobic amino acids (13). Eep, a zinc-dependent membrane metalloprotease, 
has been shown to be involved in processing the lipoprotein precursor, leading to production of 
the active pheromone in most but not all pheromone systems (14, 15). A recent study by Hancock 
et.al (submitted PNAS) showed that production of a specific pheromone, cOB1, by commensal E. 
faecalis in the gastrointestinal tract consortium, inhibits the vancomycin resistant hospital-adapted 
E. faecalis strain V583. A transposon screen to identify additional functions involved in this 
peptide-mediated antagonism led to the identification of mutants that were defective in inhibiting 
V583.  A series of independent transposon mutants whose insertion localized to    well-conserved 
genes encoding a predicted ABC transporter that belongs to the EcsAB family (16) were identified. 
49 
 
It was therefore of interest to further characterize this mutant to determine the extent to which the 
well-conserved transporter contributes to generalized pheromone production in E. faecalis.  We 
have designated this ABC transporter as the Peptide Pheromone Transporter (PptAB) to reflect its 
global role in peptide secretion.  
MATERIALS AND METHODS: 
Bacterial Strains, Plasmids & Growth Conditions: 
Bacterial strains and plasmids used in the current study are listed in Table 2-1 and Table 2-2.  



























This study, pSV06 SV02 
SV04 FA2-2ΔpptAB, Rifr This study 
SV05 FA2-2Δeep, Rifr 
 
(20) 
SV06 FA2-2ΔpptAB::pptAB, Rifr 
 
This study, pSV06 SV04 
VT09 V583 (pMV158GFP), GFP+ Tetr (21) 
SV20 SV02 (pMV158GFP), GFP+ Tetr This study 










OG1SSp (pAM714) Specr Strepr Ermr 
 
pAM714§, (23) 





   a Rifr , rifampicin resistance ; Specr , spectinomycin resistance ; Strepr , streptomycin resistance ; Tetr ,  tetracycline 
resistance ; Ermr , erythromycin resistance, § - Pheromone responsive plasmids 
Table 2-1: Bacterial strains. 
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Strains were cultured in Todd-Hewitt broth (THB) and grown at 37˚C unless otherwise indicated. 
E. coli Electro-Ten Blue (Stratagene, La Jolla, CA) was used for maintenance and propagation of 
plasmid constructs.   
§ - Pheromone responsive plasmids 
Table 2-2: Plasmids. 
Antibiotics for selection included Chloramphenicol at 10 µg-ml-1 , Rifampicin at 100 µg-ml-1, 
Tetracycline at 10 µg-ml-1  , Erythromycin at 10µg-ml-1 , Spectinomycin at 500 µg-ml-1 and 
























pLT06 containing a ~4Kb BamHI/SphI fragment encompassing pptAB the  ~1Kb 
regions flanking the 5’ and 3’ ends of pptAB 
 
pMV158GFP                   
 








Pheromone responsive plasmid harboring erythromycin resistance, Derivative of 




Pheromone responsive plasmid harboring Tetracycline resistance,  Derivative of 








A mutant transposon library was constructed in E. faecalis strains FA2-2 and OG1RF using the 
transposon mutagenesis vector pCAM45 (27). Electrocompetent E. faecalis were prepared as 
described previously (29).  Briefly, pCAM45 (1 µg) was electroporated into E. faecalis strains (2.5 
kV, 200 Ohms, 25 µF) in 0.2 cm electroporation cuvettes. Cells were allowed to recover for 2 
hours at 30°C in 1 ml SGM17MC recovery medium before plating on THB containing 
erythromycin (50 µg-ml-1) and kanamycin (2000 µg-ml-1).  Plates were incubated for 48-72 hours 
and resulting colonies were grown in THB broth supplemented with erythromycin at 20 µg-ml-1. 
Following overnight growth at 30°C, cells were diluted 1:100 into fresh THB and incubated for 2 
½ hours at 30°C and then shifted to 42 °C for 2 hours. After the 42°C incubation step, cells were 
serially diluted and plated onto pre-warmed THB plates containing 20 µg-ml-1 erythromycin and 
incubated at 42°C overnight to obtain the transposon mutant library.   
 Screen for inhibitory activity against V583: 
To identify OG1RF and FA2-2 mutants that no longer possessed the inhibitory activity against 
V583, a growth inhibition bioassay was performed.  Briefly, 250 µl of an overnight culture of 
V583 was suspended in 7.5 ml of THB soft agar.  The soft agar suspension was overlaid onto THB 
agar containing either the OG1RF or FA2-2 transposon mutants plated at a density of 200-300 
colonies per plate.  Colonies that failed to exhibit inhibitory activity against V583 were picked 
onto a THB agar plate containing rifampicin at 100 µg ml-1 and fusidic acid at 50 µg ml-1 to select 




Mapping of transposon integration sites: 
To map the location of the transposon in the mutants identified in the V583 killing screen, we 
sequenced the flanking DNA by amplifying the region surrounding the transposon insertion via 
PCR with a primer specific to one end of the Himar 1 transposon (VT01) and an arbitrary primer 
(VT02) with a constant region at the 5′ end. In a second round of PCR, a specific nested primer 
(VT04) to the Himar 1 transposon was used with a primer specific to the constant region of the 
arbitrary primer (VT03). The resulting product was sequenced by using a third nested primer 
(VT05) specific to the transposon as described previously (30).  Briefly, a colony from the 
transposon mutant was suspended in 15 μl of ddH2O. Two microliters of the suspension was added 
to 48 µl of a PCR master mix containing 5 µl of 10 X Taq Buffer, 1 µl of 50 mM MgCl2, 4 µl 
dNTP’s at 2.5 mM, 1 µl primer VT01, 1 µl primer VT02, 35.8 µl of ddH2O, and 0.2 µl of Taq 
polymerase (1 unit).  Following the 1st round of PCR, products were diluted 1:25 and 5 µl of the 
diluted suspension was added to 45 µl of master mix containing: 5 µl of 10 X Taq Buffer, 1 µl of 
50 mM MgCl2, 4 µl dNTP’s at 2.5 mM, 1 µl primer VT04, 1 µl primer VT03, 35.8 µl of ddH2O, 
and 0.2 µl of Taq polymerase (1 unit).   To sequence the resulting PCR products, primer VT05 
was used.   
Construction of E. faecalis pptAB in-frame deletion mutant: 
In frame deletion of pptAB was performed using a plasmid derived from pLT06 (25).  Briefly, 
flanking regions (~1Kb) from both the 5’ and 3’ ends of the pptAB ABC transporter were PCR 
amplified by using the primers listed in Table 2-3. For the construction of the pSV02 plasmid 
(pptAB deletion) the primers PptABP1 and PptABP2 were used to amplify the region 5’ to the 
translation start site of pptA on the V583 genome. Primers PptABP3 and PptABP4 were used to  
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Primer Name Sequence Information 
PptAB-P1 5’ GTGTGTCAGGTAATTCAGCC 3’ 
PptAB-P2 5’ CATTTCACCAGACTTGACGTC 3’ 
PptAB-P3 5’ TTCTGGGTGCCTTAATTGTAG 3’ 
PptAB-P4 5’ TTGGTGATGACGAACAATCTC 3’ 
PptAB-Up 5’ GAAAGAGTCTCAGGCATAG 3’ 
PptAB-Down 5’ AAACGACCTTTACCTGAACC 3’ 
VT01 5’ TTAAGATACTGCACTATCAACACACTC 3’ 
VT02 5’ GGCCAC GCGTCGACTAGTACNNNNNNNNNNGTAAT 3’ 
VT03 5’ GGCCACGCGTCGACTAGTAC 3’ 
VT04 5’ CTTCGATAT CAAGGGCGAATTCGC 3’ 
VT05 5’ CGAGGGGTATCGCTCTTGAAGGG 3’ 
 
Table 2-3: List of oligonucleotides used in this study. 
 
amplify the region 3’ to the translation stop site of pptB. The PptABP1 and PptABP2 region 
contained EcoRI and BamHI sites and PptABP3 and PptABP4 contained BamHI and SphI sites. 
Each product was cut with BamHI, religated and reamplified with primers PptABP1 and PptABP4 
to obtain an amplicon deleted for the pptAB genes.  This amplicon was digested with EcoRI and 
SphI and ligated into similarly digested pLT06.  Insert and vector were ligated and electroporated 
into competent E. coli ElectroTen-Blue cells (Stratagene, La Jolla, CA). Constructs were screened 
by colony PCR and positive clones were further confirmed by restriction mapping and DNA 
sequencing.  The plasmid construct, designated pSV02 containing the deletion construct for pptAB, 
was  electroporated into electrocompetent E. faecalis FA2-2 or V583 cells (29).  SV02 
[V583ΔpptAB] and SV04 [FA2-2ΔpptAB] were generated following the protocol previously 
described (31).  Mutants were confirmed by PCR using the primers PptABUp and PptABDown.   
Complementation of E. faecalis FA2-2 and V583 in-frame pptAB deletion mutants: 
The in-frame pptAB deletion mutant in FA2-2 and V583 were complemented by using a previously 
described pLT06 vector system based knock-in strategy (32). For the construction of the 
complementation vector pSV06, primers PptABP1 and PptABP4 were used to amplify a ~4Kb 
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region containing the pptAB gene and the ~1Kb flanking regions on either side, from the V583 
genomic DNA. This product was then cut with EcoRI and SphI and ligated into pLT06 cut with 
the same enzymes. The remaining steps were done similar to the procedures described above.  
Strains possessing the complemented pptAB were designated SV06 [FA2-2Δ pptAB::pptAB] and 
SV18 [V583Δ pptAB::pptAB], respectively. 
Cell aggregation Assay: 
Clumping activity was assayed using a protocol modified from Mori et al. (33). E. faecalis 
OG1SSp cells containing the different pheromone responsive plasmids pCF10, pAM714 (A pAD1 
plasmid derivative) and pAM378 (A pAM373 plasmid derivative) were used as the donor cells. E. 
faecalis FA2-2 wild-type, ΔpptAB [SV02], and complement strain [SV06] were used as the 
recipients. Briefly, the donor cells and the recipient cells were grown overnight at 37˚C in 2 ml of 
THB. 50 µl of each donor cell was added to 450 µl of either FA2-2, SV04, or SV06 and this 
mixture was added to 4.5 ml of fresh THB medium. The cultures were grown at 37˚C in a shaking 
incubator (~ 200 rpm) for 4 hours to visually compare the difference in clumping phenotype. 
Transconjugation assay: 
Transconjugation efficiency was calculated using a mating assay modified from Mori et al. (33). 
After incubating the donor and recipient cells together for 4 hours under shaking condition [200 
rpm], the cell cultures from the different plasmid systems were serially diluted in sterile PBS and 
track-diluted (34) onto THB containing rifampicin 100 μg-ml-1 and tetracycline 15 μg-ml-1 (for 
pCF10 and pAM378 transconjugants) or THB containing rifampicin 100 μg-ml-1 and erythromycin 
10 μg-ml-1 (for pAM714).  The cultures were also track-diluted onto THB plates containing 
spectinomycin at 500 µg-ml-1, and streptomycin at 500µg-ml-1 to select for donor cells in all three 
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plasmid systems. Transconjugation efficiency was measured as the ratio of transconjugants to 
donor cells. For the exogenous addition of cAM373 and cCF10, 1mM stock solution of chemically 
synthesized cAM373 was prepared in 50% acetonitrile solution and 1mM stock of cCF10 was 
prepared in dimethyl formamide and these were serially diluted to obtain the working 
concentrations.  Working stocks were added to the transconjugation reactions as indicated in 
Figure 2-7. 
Confocal Biofilm analysis: 
Confocal laser scanning microscopy (CLSM) was performed on 1-day-old biofilms as described 
previously (21). E. faecalis strains SV02 and SV18 were transformed with pMV158GFP to 
generate SV20 and SV23, respectively, as both these strains expressed GFP constitutively. VT09 
[V583(pMV158GFP)] (21) along with SV20 and SV23 were used for confocal microscopy 
analysis. Briefly, biofilms were grown on sterile glass coverslips placed in six-well tissue culture 
plates. 5ml of TSB containing tetracycline was added to the wells containing the coverslip for 
plasmid maintenance. After 24 h of growth, the biofilms were gently washed with sterile 
phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4 
[pH 7.4]) and stained with 1 μM SYTOX orange (Invitrogen) for 6 to 7 min. The coverslips were 
inverted on a clean glass slide and sealed using clear nail polish. The biofilm was visualized using 
a Zeiss LSM 5 Pa laser scanning confocal microscope. 
Growth Curve analysis: 
Standard growth curve analysis was performed to ensure that SV04 [ΔpptAB] and SV06 [pptAB 
complement] did not exhibit growth defects relative to the parental FA2-2 strain.  Briefly, FA2-2, 
SV04 and SV06 were grown in THB overnight at 37˚C. The overnight cultures of these strains 
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were inoculated into 50ml tubes containing sterile THB at a 1:100 ratio and were incubated at 37 
˚C. Samples from each tube were aseptically withdrawn every hour and the optical density was 
measured at a wavelength of 600nm through stationary phase growth (~ 8 hours). 
Skim milk plate Assay: 
Skim milk plate assay was performed by spotting 5 μl of an overnight culture of FA2-2, OG1RF, 
OG1RF::ef0689a and OG1RF::ef0689b onto a THB plate containing 1.5% skim milk. The plate 
was incubated overnight at 37 ˚C and the zone of clearance was observed. 
 
RESULTS: 
Transposon screen identified mutants with altered activity at inhibiting V583: 
With the goal of identifying factors that contributed to the pheromone-mediated killing of V583, 
a transposon mutagenesis screen was performed to identify genes whose protein products 
contribute to the inhibition of E. faecalis V583.  A recent study by Gilmore et al. (PNAS submitted) 
identified the peptide pheromone, cOB1, as being responsible for the growth inhibition of strain 
V583.  We anticipated that mutants discovered in such a screen would identify factors important 
in the synthesis of the cOB1 peptide pheromone.  To address possible strain differences that might 
contribute to pheromone-mediated killing, we subjected strains E. faecalis strains FA2-2 and 
OG1RF to transposon mutagenesis using the Himar transposon in plasmid pCAM45 (27). Previous 
studies with OG1RF demonstrated a role for GelE in the turnover of peptide pheromones (35), and 
strain FA2-2 possesses a deletion that encompasses most of the fsr quorum sensing system and 
renders it less proteolytic than OG1RF (36).  Transposon mutants from both strains were screened 
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for the ability to inhibit the growth of strain V583.  In total, ~ 30,000 mutants were screened from 
both libraries, and 10 unique transposon insertions localizing to 7 predicted gene products were 



















ef2470 (2, 1) 
 
Hypothetical Protein 
FA2-2 ef0252  (11, 2) N-acetylmuramoyl-L-alanine 
amidase 
FA2-2 ef2556 (1, 1) Putative Cation Transporter 













ef0689 (2, 2) 
 
 




ef1723 (1, 1) 
 
 
Lipoprotein Signal Peptidase 
   
* Gene locus only found in the annotated E. faecalis 62 genome, all the other gene loci are reported based on 
sequence similarity to V583 gene designations for the genes disrupted in FA2-2 and OG1RF.   
Table 2-4: Transposon gene disruption targets. 
Predictably, we identified a transposon insertion in the OG1RF library that localized to EF1723, a 
predicted lipoprotein signal peptidase (LspA), thought to be responsible for cleaving lipoproteins 
at the conserved cysteine in the lipobox domain (37).  Additional mutants were identified with 
insertions in EF0252, a predicted CHAP-domain containing amidase, a cation transporter 
(EF2556) as well as two predicted hypothetical proteins (EF2470 and EF62_1081).  Our attention 
was focused on insertions that were confined to a predicted ABC transporter, as independent 
transposon insertions localized to either the putative ATP-binding cassette (EF0688) or the 
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predicted permease (EF0689) of the ABC transporter in both the FA2-2 and OG1RF transposon 
libraries.     
                                         
Figure 2-1: Growth Inhibition Assay.  A) FA2-2 B) FA2-2::ef0688 C) OG1RF::ef0689a D) 
OG1RF::ef1723(lspA) E) OG1RF F) OG1RF::ef0689b. Strains were streaked onto THB agar and grown 
overnight at 37°C, and then the indicator strain V583 was added in a soft agar overlay.  Zones of clearance 
around the strains are indicative of growth inhibition of V583. 
 
EF0688 shares 62% sequence identity (82% sequence similarity) with the Bacillus subtilis EcsA, 
a predicted ATP-binding cassette containing protein.  EF0689 shares 30% sequence identity (52% 
sequence similarity) with the B. subtilis EcsB, a predicted ABC transporter permease.  In B. 
subtilis, EcsAB has been shown to play an important role in exoenzyme secretion (E), competence 





Disruption of the permease encoded by EF0689 does not alter exoprotease production in E. 
faecalis: 
E. faecalis is not known to be naturally competent and lacks the sporulation machinery.  We tested 
whether this transporter was involved in exoenzyme secretion in E. faecalis, as an ecsAB mutant 
in Staphylococcus aureus also resulted in changes to its secretome (38).  Since strain OG1RF 
possesses a functional Fsr system and actively secretes the only known exoproteases (gelatinase 
and serine protease) in a quorum-dependent manner, we examined the proteolytic activity of the 
parental strain and the two independent transposon insertion mutants in the ecsB homolog, ef0689, 
which we now refer to as pptB.   







Figure 2-2: Milk Protease Assay. 5µl of FA2-2; OG1RF; OG1RF::ef0689a; OG1RF::ef0689b overnight 
cultures were spotted onto THB agar medium containing 1.5% skim milk. The plate was incubated 
overnight at 37˚C.  Zones of clearance around the spotted cultures are indicative of protease activity.   
 
As noted in figure 2-2, there was no apparent change in the level of proteolytic activity between 
the strains, suggesting that the ABC transporter does not affect exoprotease secretion in E. faecalis.  
In contrast, the known Fsr-deficient strain FA2-2 produces basal protease activity on skim milk 
agar. As previously stated, gelatinase has been shown to cleave peptide pheromones and this 




activity reduces the mating efficiency between donor and recipient strains (35).  In addition, 
gelatinase is also responsible for the proteolytic activation of the major autolysin, AtlA, and this 
leads to targeted lysis of bystander cells in a process termed fratricide (39).  To both confirm the 
transposon mutant phenotype as well as generate a markerless mutation, we generated an in-frame 
deletion of both ef0688 (pptA) and ef0689 (pptB) in the FA2-2 strain background to minimize the 
contribution of gelatinase in subsequent assays.  This mutant was designated FA2-2ΔpptAB.   
 
 
Figure 2-3:  Bacterial growth curves.  E. faecalis strains FA2-2, FA2-2ΔpptAB and FA2-2ΔpptAB::pptAB 
were grown under static conditions in THB broth at 37°C and samples were analyzed by optical density 
absorbance (OD600). 
 
Additionally, we created a complemented strain in which pptAB was genetically restored to its 
native locus, using a gene knock-in strategy (32), and this strain was designated FA2-
2ΔpptAB::pptAB.  We compared the growth of the FA2-2 parental strain along with the pptAB 
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deletion mutant and the complement in Todd-Hewitt broth and found that the growth for all three 
strains were nearly identical throughout the growth cycle (Fig. 2-3)  
 
cOB1 is not detected in the culture supernatant of the pptAB deletion mutant: 
To confirm that the lack of inhibition of V583 by the FA2-2ΔpptAB strain was due to the absence 
of secreted cOB1, we analyzed the culture supernatants from both FA2-2 and the pptAB deletion 
mutant for the presence of cOB1.                                              
                                                       
Figure 2-4:  Analysis of the supernatant to identify c0B1. FA2-2 (A) and FA2-2ΔpptAB (B) were grown 
in chemically defined medium (CDM) overnight.  Spent culture supernatants were analyzed by High 
Pressure Liquid Chromatography (HPLC). The peak present in panel A shows the relative amount of cOB1 
eluted between 17-19 minutes. The time scale is in minutes. Experiment performed by Dr. John M. Tomich. 
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Strains were grown in complete defined medium (CDM) (40) to reduce the complexity of detecting 
a short hydrophobic peptide in rich lab medium.  Spent culture supernatants from overnight 
cultures were harvested for HPLC analysis to identify the presence of cOB1. As expected, we were 
unable to detect cOB1 in the supernatant from the pptAB mutant, whereas detectable cOB1 signal 
was observed in the parental FA2-2 (Fig. 2-4).  
 
The ∆pptAB mutant fails to aggregate in clumping assays with donor cells possessing a 
pheromone responsive plasmid: 
The inability to detect cOB1 in the supernatant of a pptAB mutant suggested that the PptAB ABC 
transporter might be a global pheromone exporter. A hallmark of pheromone-mediated 
conjugation in broth matings is the formation of cellular aggregates or “clumps”, and is indicative 
of a co-aggregation event between donor and recipient cells, recently reviewed by Clewell et al. 
(9).  Plasmid-bearing donor cells respond to the presence of peptide pheromones produced by the 
recipient to induce the expression of conjugation machinery that also includes aggregation 
substance.  Clumping occurs when aggregation substance on the donor cell binds to binding 
substance on the recipient to facilitate mating bridge formation and subsequent transfer of the 
plasmid from donor to recipient. The cell aggregation assay was performed using FA2-2, FA2-
2ΔpptAB, and the complement strain FA2-2ΔpptAB::pptAB as recipient cells and OG1SSp 
(pCF10) as the donor cell. The transconjugation mixture containing the parental strain FA2-2 and 
the complement strain showed visible clumping with the OG1SSp (pCF10) donor while ΔpptAB 
mutant failed to induce detectable clumping (Fig. 2-5), suggesting that the peptide pheromone 




                  
Figure 2-5: Clumping assay using FA2-2, FA2-2ΔpptAB, FA2-2ΔpptAB::pptAB as recipients. The 
OG1SSp donor cells harbored the pCF10 plasmid. After the donors and recipients were mixed and 
incubated for 4hrs under rigorous shaking conditions (200 rpm), the tubes were placed horizontally to 
visualize the extent of cell clumping and photographed. 
 
Mating efficiency is significantly attenuated by deletion of the PptAB transporter: 
Since the pptAB mutant showed no visible clumping in the cell aggregation assay, we examined 
whether the mating efficiency between the donor and recipient cells was affected in a broth mating 
assay and extended the observations to 3 unique and well-characterized pheromone responsive 
plasmid systems (pCF10, pAD1 and pAM373). The broth mating assay (33) involved the OG1SSp 
donor cell harboring either pCF10, pAM714 (23) and pAM378 (24) and recipient cells: FA2-2, 
FA2-2ΔpptAB, FA2-2ΔpptAB::pptAB, and as a control FA2-2Δeep (20). The cells from each 
transconjugation mixture were serially diluted and plated onto medium containing antibiotics to 
select for transconjugants and onto to separate medium to select only for donors in order to 
calculate the transconjugation efficiency [# of transconjugants / # of donors].  The results of the 






Table 2-5: Transconjugation efficiency. 
 
We observed that in all three plasmid systems, the mating efficiency of the ΔpptAB mutant was 
significantly impaired, displaying a 5-6 log reduction in mating efficiency compared to the 
parental. The complemented strain was restored to wild-type levels in all 3 systems, whereas the 
eep mutant exhibited a 2-3 log reduction as compared to the wild-type with plasmids pCF10 and 
pAM714.  In contrast, the eep mutant did not exhibit a significant change from wild-type levels 
with the pAM378 plasmid, which is consistent with a previous report (14) that demonstrated a role 













5.3X10-1 ± 3.6X10-1 
 





3.7X10-7 ± 0.8X10-7 
 
 
 1.0X10-6 ± 0.2X10-6 
 
 








9.3X10-1 ± 7.5X10-1 
 





5.0X10-4 ± 4.5X10-4 
 
 
  1.3X10-3 ± 0.2X10-3 
 
  8.6X10-1 ± 8.0X10-1 
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Figure 2-6: Recipient strains FA2-2, FA2-2ΔpptAB, FA2-2ΔpptAB::pptAB, and FA2-2Δeep were mixed 
with the donor strain OG1SSp possessing the indicated pheromone responsive plasmid:  A) pCF10 B) 
pAM714 and C) pAM378. After mixing, donors and recipients were incubated for 4hrs under rigorous 
shaking conditions.  Following a series of 10-fold dilutions, 5µl of diluted culture was spotted onto plates 




Exogenous Addition of Purified Sex Pheromone Complements for the Absence of the 
Transporter: 
To determine whether the pptAB mutant was defective in cell aggregation assays and mating assays 
solely due to its inability to secrete peptide sex pheromones, we sought to complement the pptAB 
mutant phenotypes using synthetic pheromones.       
                
Figure 2-7: Exogenous addition of purified A) cAM373 and B) cCF10 restores mating defect of the pptAB 
mutant. Purified cAM373 and cCF10 at the concentrations indicated was added to the transconjugation 
mixture in which FA2-2ΔpptAB was used as a recipient. OG1SSp(pAM378) and OG1SSp(pCF10) were 
used as donors. FA2-2 parental strain was also used as a control recipient strain. 10 µl of all reactions were 
serially diluted and spotted on THB agar plates containing rifampicin at 10 µg ml-1 and tetracycline at 10 
µg ml-1 to select for transconjugants. 
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Cell aggregation assays and mating assays were performed as described above wherein OG1SSp 
(pAM378) and OG1SSp (pCF10) were used as the donors and FA2-2 or FA2-2ΔpptAB was used 
as the recipient.  Synthetic cAM373 and cCF10 were exogenously added to the corresponding 
reaction tubes containing FA2-2ΔpptAB recipient cells at varying concentration (1000 nM, 100nM 
and 1nM) and clumping was monitored. After 4 hours the cultures were plated to determine the 
mating efficiency. The results of these assays are shown in Figure 2-7. The exogenous addition of 
purified cAM373 or cCF10 restored the clumping and mating defects of FA2-2ΔpptAB recipient 
cells in the cognate pheromone responsive plasmid systems demonstrating that the inability of the 
transporter mutant to actively secrete pheromones is the basis for the observed mating defects in 
this mutant. 
 
Deletion of the Peptide Pheromone Transporter affects biofilm formation: 
Biofilm formation is a coordinated process that generally involves cell-cell communication. Since 
peptide pheromones are involved in direct cell-cell signaling, we hypothesized that the deletion 
mutant lacking the peptide pheromone transporter would display altered biofilm architecture 
compared to the parental strain.  To test this hypothesis, we engineered the clinical isolate E. 
faecalis V583 to delete pptAB as previous studies showed that it was a better biofilm former than 
FA2-2 (21, 41).  We also complemented the V583ΔpptAB mutant by restoring the pptAB genes 
back to their native locus using the gene knock-in strategy (32).  To monitor biofilm development, 
plasmid pMV158GFP was introduced into each strain to provide constitutively expressed GFP 
(26).  Confocal image analysis was performed on 1-day biofilms formed by V583, V583ΔpptAB, 







       
Figure 2-8: Confocal microscopy biofilm analysis was performed on 1-day old biofilms (A) i) V583 ii) 
V583ΔpptAB and iii) V583ΔpptAB::pptAB. All the strains contain the plasmid pMV158GFP, which 
provides constitutive expression of GFP. (B) Comstat image analysis of biofilms depicted in panel A. 
 
Consistent with our hypothesis, the pptAB transporter mutant displayed a non-confluent biofilm 
phenotype compared to the parental and complement strains.  By COMSTAT analysis (42) (Fig. 
2-8(B)), the average biofilm thickness and overall biomass were reduced by ~ 90% in the pptAB 





In this study we have shown that the EcsAB homolog in E. faecalis, which we have renamed 
PptAB to reflect its apparent global role in peptide pheromone secretion, is important in both the 
well-known cell-cell communication events in plasmid conjugation, as well as biofilm 
development.  The initial studies involving EcsAB postulated that this transporter might be 
involved in clearing the membrane from the accumulation of peptide signals, but the nature of the 
transported substrate was unknown (16, 38).  Here we have shown for the first time that an 
important substrate of the ABC transporter is the peptide signals used in pheromone mating in E. 
faecalis.  The pathway by which lipoproteins are processed leading to the production and release 
of pheromones is illustrated in Fig. 2-9. It is known that peptide sex pheromones in E. faecalis are 
derived from lipoprotein precursors (43, 44). The lipoprotein precursors are thought to be secreted 
in Gram-positive bacteria through a Sec-dependent pathway (45).  It is also known that the 
prolipoprotein diacylglyceryl-transferase (Lgt) is important in lipoprotein membrane anchorage in 
E. faecalis (46) and the lipoprotein signal peptidase (LspA), which is a type II signal peptidase is 
important for N-terminal processing of lipoproteins (47).   In the present study, our transposon 
screen confirmed a role for LspA in the production of cOB1.  An et al. (14) showed that in addition 
to these upstream processing events of the lipoprotein precursor, Eep also enhanced recovery of 
the native pheromone.  Our data extend this model further to show that the secretion of the peptide 




                     
Figure 2-9: Mechanism of peptide sex pheromone production and secretion in Enterococcus faecalis. 1) 
Lipoprotein produced in the cytoplasm is exported out through the secretory apparatus. 2) Lgt diacylates 
the lipoprotein at the conserved cysteine (Indicated by C) and anchors it to the membrane. 3) Lsp, a signal 
peptidase-2 cleaves the N-terminal overhang from the conserved cysteine. 4) Eep, a membrane embedded 
zinc-metalloprotease further degrades the N-terminal overhang to produce pheromones. 5) PptAB, the 
peptide transporter actively transports these pheromones outside the cell. 
 
This is supported by two important observations 1) the addition of exogenous peptide restores the 
mating deficiency when the pptAB mutant is used as the recipient and 2) the peptide pheromone 
transporter mutant can function as a donor and efficiently transfer a pheromone responsive plasmid 
to a recipient suggesting that the inability to secrete peptide sex pheromones does not affect this 
mutant’s ability to function as a pheromone responsive donor (Table 2-6). It is important to note 
that an eep deletion mutant shows only a partial attenuation in mating efficiency compared to the 
pptAB deletion mutant. This could possibly be due to the presence of a secondary protease that 
might be compensating for the activity of Eep, as was observed with LspA and Eep in 
Streptococcus uberis (48). The other possibility is that the peptide pheromone transporter might 
still be exporting the pre-pheromones with less efficiency compared to the processed pheromone, 
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and that these pre-pheromones may retain biological activity.  Confirming these hypotheses is the 
current focus of ongoing studies in the lab.   
 
 
Table 2-6: Transconjugation efficiency with FA2-2ΔpptAB as a donor. 
 
A recent study showed that peptide pheromones mediate biofilm formation in Streptococcus 
pyogenes by interacting with the Rgg family of transcriptional regulators (49). A study by 
Shelburne et al. (50) identified the secretion signal sequence from the S. pyogenes protein Vfr as 
a peptide pheromone that coordinates the activity of another Rgg family member, the RopB 
repressor.  Recent work by Serror’s group (51) identified an Rgg-homolog in E. faecalis, which 
they termed ElrR, as it was shown to positively regulate the expression of the enterococcal leucine-
rich protein ElrA, but whether ElrR also regulates biofilm development is not presently known.  It 
is possible that unidentified peptide pheromones of E. faecalis regulate biofilm formation, but 
whether those sequences derive from lipoprotein signal sequences, other secretion signal 
sequences or additional SHP-like sequences awaits further study to determine if PptAB is directly 
involved in the secretion of these peptides.  Deciphering the link with PptAB and biofilm formation 
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development. Bioinformatic analysis revealed that the peptide pheromone transporter is highly 
conserved across the pathogenic Firmicutes (Fig. 2-10).  Pheromone mediated transfer of genetic 
material is a hallmark of enterococcal biology allowing the acquisition of a variety of antibiotic 
resistance traits, making them a more persistent pathogen in the hospital setting (52), which may 
also disseminate resistance to other problematic pathogens. Studies have shown that clinical 
isolates of Staphylococcus aureus obtained vancomycin resistance gene via the conjugative 
transposon Tn1546 present in the co-infecting E. faecalis isolate (53, 54). This is attributed to the 
fact that S. aureus produces a pheromone, derived from a lipoprotein signal sequence, which is 
known to mimic the enterococcal pheromone cAM373, enabling exchange of genetic information 
between these two species (5). Recently, a genetic determinant in Streptococcus gordonii encoding 
a predicted lipoprotein was also identified as a precursor for a peptide pheromone resembling 
cAM373, which enables intergeneric DNA transfer between E. faecalis and S. gordonii (55). It is 
also interesting to note that peptide signaling has been employed by other gram-positives to 
perform a variety of cellular functions including competence, sporulation and biofilm 
development. In B. subtilis, Phr pentapeptides have been shown to be important for competence 
and sporulation initiation (56).  In naturally transformable Streptococcus mutans, SigX-regulated 
genes are involved in the competence cascade, and SigX is regulated by ComR.  ComR is a 
transcriptional regulator of the Rgg family, which is known to bind peptides derived from ComS 
(XIP).  The XIP peptides are thought to be exported through an unidentified membrane transporter 
(57).  More recently, Chang et al. showed that SHP pheromones, which affect virulence in S. 
pyogenes by binding Rgg, are processed by Eep, and are transported outside the cell by an 
unknown transporter (49).  
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Figure 2-10: Multiple sequence alignment of PptB (EcsB) homologs from various pathogenic Firmicutes. 
Amino acids highlighted in red are conserved across all the above bacterial species. 
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Phr, XIP and SHP pheromones are hydrophobic in nature, as are the peptide pheromones that 
mediate conjugation in E. faecalis. Based on the observations we report in this study and the 
conservation of the PptAB (EcsAB) ABC transporter among pathogenic gram-positives, it is 
coherent to speculate that this transporter might be serving the same important peptide secretory 
function in these pathogenic species as in E. faecalis. Further characterization of this conserved 
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DISCOVERY OF A SECOND OLIGOPEPTIDE PERMEASE COMPLEX IN 
Enterococcus faecalis 
 











Exchange of genetic information in enterococci occurs through the process of conjugation wherein 
a donor cell harboring a pheromone responsive plasmid responds to short (7-8 amino acid) 
predominantly hydrophobic peptide pheromones produced by the recipient cell. The oligopeptide 
permease (opp) operon encodes for proteins that aid in the import of these pheromones into the 
donor cell (1). Using a bacterial killing assay dependent on the presence of the sex pheromone 
cOB1, we show that a V583∆opp1 mutant only displays partial resistance to the inhibitory peptide 
pheromone cOB1 compared to the wild-type. A database search of the V583 genome identified a 
previously uncharacterized operon predicted to encode proteins with functions similar to 
oligopeptide permeases.   Deletion of this second operon, which we termed opp2, in V583 also 
conferred partial resistance to cOB1.  In contrast, the double mutant strain (Δopp1Δopp2) was 
completely resistant to cOB1 suggesting that the two Opp complexes are functionally redundant. 
Individual opp mutants exhibited only a minor decrease in mating efficiency, whereas the double 
Opp- mutant strain was highly attenuated as a donor in transconjugation assays involving distinct 
pheromone responsive plasmid systems.  Confocal image analysis on 1-day biofilms revealed a 
significant decrease in the ability of the double Opp- mutant to form confluent biofilms compared 
to the wild-type suggesting the importance of peptide pheromone transport in biofilm formation. 
The opp double mutant and a deletion mutant (pptAB) for a previously reported ABC transporter 
involved in peptide pheromone secretion were also significantly attenuated in a Caenorhabditis 
elegans model of infection compared to the wild-type, indicative of a possible role played by these 





Enterococcus faecalis is an opportunistic pathogen that has emerged among the vanguard of multi-
drug resistant microorganisms. Peptide pheromones play critical roles in cell-cell communication 
by contributing to the development of increased virulence and antibiotic resistance in 
Enterococcus faecalis (2-6) through induction of horizontal gene transfer (7). This is 
predominantly due to the fact that pheromone responsive plasmids which aid the donor cells in 
responding to the pheromones secreted by the recipient cells, are known to harbor antibiotic 
resistance genes as well as known virulence factors including the cytolysin and aggregation 
substance (8, 9). Recent data provide additional evidence that pheromone mediated transfer of 
antibiotic resistance also occurs at an inter-species level (10, 11). Staphylococcus aureus (11) and 
Streptococcus gordonii (10) have been shown to produce pheromones to which E. faecalis 
responds and this results in the transfer of the pheromone responsive plasmid pAM373 to these 
recipients. A number of factors are involved in the process of conjugation and the functional role 
of many of the plasmid-encoded gene products in E. faecalis have been delineated (12-14).  
A study by Leonard et al. (1) showed that E. faecalis donor cells harboring the pheromone 
responsive plasmid pCF10 respond to the recipient cells by actively importing the cognate peptide 
sex pheromone cCF10 via the oligopeptide permease (Opp) complex (EF_0907 - EF_0912). The 
Opp complex consists of five proteins, including two transmembrane proteins (OppB and OppC), 
two ATP binding proteins (OppD and OppF), and a cell membrane anchored lipoprotein (OppA) 
which binds to pheromones with high affinity to direct the pheromone into the donor cell. It is also 
important to note that the pheromone responsive plasmids encode OppA homologs (PrgZ or TraC) 
that bind to their cognate pheromones with much higher affinity compared to OppA and hijack the 
chromosomally encoded Opp system to import these pheromones into the cell (1, 15, 16). We took 
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advantage of the fact that the peptide sex pheromone cOB1 inhibits the growth of E. faecalis strain 
V583 to determine whether a V583 strain lacking the aforementioned Opp complex was 
susceptible to the inhibitory effect of this pheromone (M. S. Gilmore, M. Rauch, M. Ramsey, P. 
Himes, S. Varahan, F. Lebreton, and L. E. Hancock, submitted for publication) (17). Interestingly, 
V583∆opp1 was only partially resistant to cOB1-mediated growth inhibition. This led us to 
hypothesize that E. faecalis might possess an additional oligopeptide permease complex. Careful 
examination of the E. faecalis V583 genome resulted in the identification of a second oligopeptide 
permease complex (EF_3106 - EF_3110).  It was therefore of interest to further examine the 
contribution of both Opp systems to pheromone mating as well as biofilm development in E. 
faecalis. Our data show that the deletion of both of the E. faecalis oligopeptide permease 
complexes results in the failure of this bacterium to respond as a donor to three distinct peptide 
sex pheromones (cCF10, cAD1 and cAM373), attenuates biofilm development in-vitro and 
reduces virulence in a C. elegans infection model. 
 
MATERIALS AND METHODS: 
Bacterial Strains, Plasmids & Growth Conditions: 
Pertinent bacterial strains and plasmids used in the current study are listed in Table 3-1 and Table 
3-2.  E. faecalis strains were cultured in Todd-Hewitt broth (THB) and grown at 37˚C unless 
otherwise indicated.  Escherichia coli ElectroTen-Blue (Stratagene, La Jolla, CA) was used for 
maintenance and propagation of plasmid constructs.  ElectroTen-Blue clones were cultured 
aerobically in Luria-Bertani broth at 37˚C.  Antibiotics for selection included chloramphenicol at 




Table 3-1: Bacterial strains used in this study. 
 
Strain Genotype or description Reference 
V583 Parental Strain (18)  
OG1RF Parental Strain Rifr  Fusr (19) 
OG1SSp Parental Strain  Specr Strepr (20) 
SV02 V583∆pptAB (17) 
KS22 OG1RF∆gelE (21) 
SV26 V583∆opp1 This Study 
SV27 V583∆opp2 This Study 
SV28 V583∆opp∆opp2 This Study 
VT01 V583(pMV158GFP) GFP+ Tetr (22) 
SV29 V583∆opp1(pMV158GFP) GFP+ Tetr This Study 
SV30 V583∆opp2(pMV158GFP) GFP+ Tetr This Study 
SV31 V583∆opp∆opp2 (pMV158GFP) GFP+ Tetr This Study 
SV74 OG1RF∆gelE∆opp1 This Study 
SV91 OG1RF∆gelE∆opp2 This Study 
SV92 OG1RF∆gelE∆opp1∆opp2 This Study 
SV75 OG1RF∆gelE(pCF10)£  Tetr This Study 
SV76 OG1RF∆gelE(pAM714)£ Ermr This Study 
SV77 OG1RF∆gelE(pAM378)£  Tetr This Study 
SV78 OG1RF∆gelE∆opp1(pCF10)£  Tetr This Study 
SV79 OG1RF∆gelE∆opp1(pAM714)£  Ermr This Study 
SV80 OG1RF∆gelE∆opp1(pAM378)£  Tetr This Study 
SV93 OG1RF∆gelE∆opp2(pCF10)£  Tetr This Study 
SV94 OG1RF∆gelE∆opp2(pAM714)£  Ermr This Study 
SV95 OG1RF∆gelE∆opp2(pAM378)£  Tetr This Study 
SV96 OG1RF∆gelE∆opp1∆opp2 (pCF10)£  Tetr This Study 
SV97 OG1RF∆gelE∆opp1∆opp2 (pAM714)£  Ermr This Study 
SV98 OG1RF∆gelE∆opp1∆opp2 (pAM378)£  Tetr This Study 
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streptomycin at 500 µg ml-1 , rifampicin at 50 µg ml-1 , tetracycline at 15 µg ml-1 and erythromycin 
at 10 µg ml-1  for E. faecalis.  Transformation of plasmids into E. faecalis strains was done as 
described previously (23). 
 
Table 3-2: Bacterial strains used in this study. 
 
Construction of E. faecalis in-frame deletion mutants: 
In frame deletions of the genes encoding the Opp1 and Opp2 complexes as well as the double 
deletion mutant of both opp1 and  opp2 in E. faecalis strains V583 and KS22 [OG1RF∆gelE] were 
completed using plasmids derived from pLT06 (24), an E. coli-enterococcal temperature-sensitive 
Plasmid Description Reference 
pLT06 Deletion vector; chloramphenicol resistance (24) 
   
pSV12 pLT06 containing engineered opp deletion (~2-kb EcoRI/PstI 
fragment)-  Deletion of opp1 in V583 and OG1RF 
This Study 
   
pSV13 pLT06 containing engineered opp2 deletion (~2-kb EcoRI/PstI 
fragment)-  Deletion of opp2 in V583 
This Study 
   
pCJK218 Modified pLT06 containing altered pheS  (25) 
   
pSV31 pCJK218 containing engineered opp2 deletion (~2-kb EcoRI/PstI 
fragment)- Deletion of opp2  in OG1RF 
This Study 
   
pMV158GFP gfp containing plasmid  (26) 
   
pCF10£ Pheromone responsive plasmid harboring tetracycline resistance (27) 
   
pAM714£ Pheromone responsive plasmid harboring erythromycin 
resistance, Derivative of pAD1£ 
(28) 
   
pAM378£ Pheromone responsive plasmid harboring Tetracycline resistance, 
Derivative of pAM373£ 
(29) 
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cloning vector that possesses selectable and counterselectable markers that aid in the selection of 
markerless mutants containing the targeted deletions. The primers used for all the deletions are 
listed in Table 3. Flanking regions (~1Kb) from both the 5’ and 3’ ends of opp1 and opp2 complex 
genes were PCR amplified by using the primers listed in Table 3-3. For the construction of the  


















    The underlined sequences denote restriction sites that were added to the template-directed sequences to facilitate cloning. 
 
Table 3-3: Primers used in this study. 
 
pSV12 plasmid (opp1 deletion) the primers Opp1P1 and Opp2P2 were used to amplify the ~1Kb 
regions flanking the 5’ end of opp1 on the V583 and KS22 genomes respectively. Primers OppP3 
and OppP4 were used to amplify the ~1Kb region flanking the 3’ end of the opp1 region in both 
strains. The OppP1 and OppP2 primers contained EcoRI and BamHI sites, respectively and OppP3 
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and OppP4 primers contained BamHI and PstI sites, respectively. Each product was digested with 
the respective restriction enzymes, and ligated to pLT06 cut with EcoRI and PstI prior to 
electroporation into E. coli ElectroTen-Blue cells. Confirmation of the appropriate clones was 
performed by restriction digest and sequence analysis.  An analogous approach was used for the 
construction of pSV13 (opp2 deletion in V583) and pSV31 (opp2 deletion in KS22 
[OG1RF∆gelE]). We were unable to use pSV13 construct for the deletion of opp2 in OG1RF since 
the opp2 flanking region in V583 is significantly different from that of OG1RF due to the presence 
of an IS element in V583. pSV13 was generated using pLT06, whereas pSV31 was generated 
using pCJK218 (a pLT06 based vector with an altered pheS synthetic sequence to reduce the 
likelihood of homologous recombination at that locus) (25). Purified plasmids from E. coli were 
electroporated into electrocompetent V583 and KS22 [OG1RFΔgelE] cells.  SV26 [V583∆opp1], 
SV27 [V583∆opp2], SV74 [KS22∆opp1], and SV91 [KS22Δopp2] were generated following the 
protocol as previously described (24). To create the double deletion of opp1 and opp2 in the V583 
strain background, electrocompetent SV26 cells were transformed with pSV13, and the deletion 
mutant was designated as SV28 [V583∆opp1∆opp2].  To create the double deletion of opp1 and 
opp2 in the strain KS22, electrocompetent SV74 cells were transformed with pSV31, and the 
deletion mutant was designated as SV92 [KS22∆opp1∆opp2].   
Growth Curve Analysis: 
Standard growth curve analysis was performed to ensure that SV26 [V583∆opp1], SV27 
[V583∆opp2] and SV28 [V583∆opp1∆opp2] did not exhibit growth defects relative to the parental 
V583 strain when grown in enriched medium (Tryptic Soy Broth). Briefly, V583, SV26 
[V583∆opp1], SV27 [V583∆opp2] and SV28 [V583∆opp1∆opp2] were grown in TSB overnight 
at 37˚C. The overnight cultures of these strains were inoculated into a 96-well plate containing 
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TSB at a 1:100 ratio and were incubated at 37 ˚C. Optical density was measured at a wavelength 
of 600 nm using the Infinite M200 Pro plate reader [Tecan US, Inc; Morrisville, North Carolina]. 
Cell aggregation Assay: 
Clumping activity was assayed using a protocol modified from Mori et al. (30). E. faecalis OG1RF, 
KS22 [OG1RF∆gelE], SV74 [KS22∆opp1], SV91 [KS22Δopp2] and SV92 [KS22∆opp1∆opp2] 
cells containing the pheromone responsive plasmids pCF10, pAM714 (A pAD1 plasmid derivative 
encoding erythromycin resistance) and pAM378 (A pAM373 plasmid derivative encoding 
tetracycline resistance) were used as the donor cells. E. faecalis OG1SSp was used as the recipient. 
Briefly, the donor cells and the recipient cells were grown overnight at 37˚C in 2 ml of THB. 50 
μl of each donor cell was added to 450 μl of OG1SSp and this mixture was added to 4.5 ml of 
fresh THB medium. The cultures were grown at 37˚C in a shaking incubator (~ 200 rpm) for 4 
hours to visually compare the difference in clumping phenotype. 
Transconjugation assay: 
Transconjugation efficiency was calculated using a mating assay modified from Mori et al. (30). 
After incubating the donor and recipient cells together for 4 hours under shaking conditions [200 
rpm], the cell cultures from the different plasmid systems were serially diluted in sterile PBS and 
track-diluted (31) onto THB containing streptomycin 500 μg-ml-1 and tetracycline 15 μg-ml-1 (for 
pCF10 and pAM378 transconjugants) or THB containing streptomycin 500 μg-ml-1  and 
erythromycin 10 μg-ml-1 (for pAM714). The cultures were also track-diluted onto THB plates 
containing rifampicin at 100 μg-ml-1 to select for donor cells in all three plasmid systems. 





Confocal Biofilm Analysis: 
Confocal laser scanning microscopy (CLSM) was performed on 1-day-old biofilms as described 
previously (22). E. faecalis strains SV26 [V583∆opp1], SV27 [V583∆opp2] and SV28 
[V583∆opp1∆opp2] were transformed with pMV158GFP to generate SV29, SV30 and SV31, 
respectively, and these strains expressed GFP constitutively. VT09 [V583(pMV158GFP)] (22) 
along with SV29 [V583∆opp1(pMV158GFP)], SV30 [V583∆opp2(pMV158GFP)] and SV31 
[V583∆opp1∆opp2(pMV158GFP)] were used for confocal microscopy analysis. Briefly, biofilms 
were grown on sterile glass coverslips placed in six-well tissue culture plates. Tetracycline was 
added to the TSB medium for plasmid maintenance. After 24 h of growth, the biofilms were gently 
washed with sterile phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 2 mM KH2PO4 [pH 7.4]) and stained with 1 μM SYTOX orange (Invitrogen) for 6 to 
7 min. The coverslips were inverted on a clean glass slide and sealed using clear nail polish. The 
biofilm was visualized using a Zeiss LSM 5 Pa laser scanning confocal microscope. 
Assay for C. elegans killing by E. faecalis: 
Bacterial strains were grown on brain heart infusion (BHI) agar medium in 35-mm tissue-culture 
plates. Lawns of V583, V583ΔpptAB, V583Δopp1, V583Δopp2 and V583Δopp1Δopp2 were 
grown as follows: 2 ml of BHI was inoculated with a single colony of the appropriate strain and 
grown at 37°C for 4–5 hr, and 35 μl of the culture was spread on each plate. The plates were 
incubated at 37°C overnight. C. elegans strain N2 was maintained and propagated on Escherichia 
coli strain OP50 with standard techniques. Between 10 and 15 C. elegans L4 or young adult 
hermaphrodites were transferred from a lawn of Escherichia coli OP50 to a lawn of the bacterium 
to be tested, incubated at 25°C, and examined at ~24-hr intervals with a dissecting microscope for 
viability. Worms were considered dead when they did not respond to touch with a platinum wire 
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pick. Each experimental condition was tested in duplicate or triplicate. Nematode survival was 
plotted with the Kaplan–Meier method using Graphpad Prism 5.0 statistical software (San Diego, 
CA). The Graphpad Prism software package was also used for testing equality of survival (Log-
Rank (Mantle-Cox test)). 
 
RESULTS: 
Discovery of a second oligopeptide permease complex in E. faecalis:     
A homology search of the E. faecalis V583 genome with genes encoding for components of the 
Opp1 complex [EF_0907 to EF_0912] first described by Leonard et al. (1) identified 5 additional 
open reading frames (ORF’s) encompassing genes EF_3106 and EF_3110.  The genes of this 
putative second opp operon along with the sequence identity shared with their Opp1 complex 




Figure 3-1: Genetic organization of opp1 and opp2 complexes in strain V583. All the corresponding 
homologs in each complex are color coded with the same color. The percentage values above the opp2 
complex indicate amino acid sequence identity of the opp2 complex genes to their corresponding homologs 
in the opp1 complex. ef_0908 is an ORF present in the opp1 complex and is not present in the opp2 complex. 
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Opp1A, the pheromone binding lipoprotein, shares 39% sequence identity with Opp2A.  Opp1B 
and Opp1C, predicted membrane permeases, share 57% sequence identity with their Opp2B and 
Opp2C counterparts. Opp1D and Opp1F, predicted ATP-binding proteins, share 65-74% sequence 
identity with Opp2D and Opp2F.  Interestingly, the small divergently transcribed and 
uncharacterized gene, ef_0908, located between the genes opp1A (ef_0907) and opp1B (ef_0909) 
is absent in the second Opp complex. Apart from the identified opp2 genes, there were no 
additional Opp-related genes present in the V583 genome.  
 
Oligopeptide permeases are essential for the import of peptide sex pheromone cOB1: 
                                                
Figure 3-2: cOB1 spot assay. A) E. faecalis strains i)V583 ii)V583Δopp1 iii)V583Δopp2 and 
iv)V583Δopp1Δopp2 were grown overnight at 37°C in THB and were spread on a plate. 100nM purified 
cOB1 peptide was spotted into the well in the middle of each plate and these were incubated overnight at 
37°C and the plates were photographed to observe the growth inhibition. B) Zones of inhibition were 
quantified and the diameter of the zones are represented in the graph. 
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A recent study (M. S. Gilmore, M. Rauch, M. Ramsey, P. Himes, S. Varahan, F. Lebreton, and L. 
E. Hancock, submitted for publication) has demonstrated that commensal E. faecalis inhibit the 
growth of strain V583, a multi-drug resistant VRE prototype of the MLST ST6 lineage  (32). The 
inhibition of V583 was due to the secretion of the peptide sex pheromone cOB1 by commensal 
strains. We wanted to test whether cOB1 was imported into V583 via either of the two oligopeptide 
permeases. Growth of V583 was substantially inhibited by the presence of cOB1, while 
V583∆opp1 and V583∆opp2 displayed partial resistance to the inhibitory effect of cOB1 (Fig 3-
2A, 3-2B). Interestingly, V583∆opp1∆opp2 was completely resistant to the inhibition by cOB1 
suggesting that in the absence of the Opp complexes, cOB1 is unable to exert its inhibitory effects 
on the growth of V583 (Fig 3-2A, 3-2B).   
 
Cell aggregation is impaired when opp complexes are deleted: 
It is known that cells that harbor pheromone responsive plasmids encode for an OppA homolog 
that binds to the cognate pheromone with higher affinity (1). The plasmid encoded OppA homolog, 
typified by PrgZ and TraC, recruits the chromosomally encoded oligopeptide permease complex 
to import the cognate pheromones (16). The uptake of pheromones results in disruption of the 
PrgX repressor function leading to increased expression of the proteins involved in conjugative 
mating (33). We hypothesized that along with the E. faecalis Opp1 complex, that the Opp2 
complex also contributes to the uptake of peptide sex pheromones and that their deletion in tandem 
would result in the attenuation of peptide uptake, leading to reduction in plasmid transfer.  To 
assess cell aggregation and plasmid conjugation, we constructed the opp complex deletions in the 
plasmid-free OG1RF strain background, as strain V583 possesses three plasmid systems, two of 




Figure 3-3: Cell aggregation assay. OG1RF, OG1RFΔgelE, OG1RFΔgelEΔopp1, OG1RFΔgelE Δopp2 
and OG1RFΔgelEΔopp1Δopp2 harboring pCF10 were the donors and OG1SSp was used as the recipient. 
After the donors and recipients were mixed and incubated at 37°C for 4hrs under rigorous shaking 
conditions (200 rpm), the tubes were placed horizontally to visualize the extent of cell clumping and 
photographed. 
 
Waters et al. (35) showed that the E. faecalis secreted zinc metalloprotease, gelatinase, is able to 
cleave peptide pheromones, which results in a partial reduction in plasmid transfer efficiency (36).  
We mobilized 3 distinct pheromones responsive plasmids pCF10, pAM714 (pAD1 derivative) and 
pAM378 (pAM373 derivative) into each strain background (Table 3-1).  These plasmid harboring 
strains were used as the donor with OG1SSp as the recipient. The donor and recipients were mixed 
at a ratio of 1:10 and the extent of cell aggregation was evaluated after 4 hours. The results of this 
assay using the pCF10 system are shown in Figure 3-3. As expected when both OG1RF and 
OG1RF∆gelE containing pCF10 were used as the donor, there was visible clumping, suggesting 
that pheromone mediated induction of conjugation machinery had occurred.  However when 
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OG1RF∆gelE∆opp1 harboring pCF10 was used as the donor there was no visible clumping 
suggesting that the Opp1 complex is the major contributor to the uptake of the cCF10 pheromone 
(Fig. 3-3). Interestingly the deletion of the opp2 operon in OG1RF∆gelE harboring pCF10 resulted 
in smaller aggregates compared to the parental strain suggesting that the Opp2 complex may 
partially contribute to the overall clumping response. Consistent with observations for the opp1 
deletion, a pCF10 donor mutant lacking both Opp systems (∆opp1∆opp2) showed no signs of 
visible clumping in response to a cCF10 producing recipient.  Similar results were seen when this 
assay was performed using donor cells harboring pAM714 and pAM378 plasmid systems (data 
not shown). 
 
Oligopeptide permease complex mutants exhibit attenuated transconjugation efficiency: 
Since the deletion of the opp complexes in donor cells harboring the pheromone responsive 
plasmids pCF10, pAM714 and pAM378 resulted in an attenuation in cell aggregation, we wanted 
to determine whether these opp deletion mutants were impaired in their ability to detect peptide 
pheromones and transfer the pheromone responsive plasmids they harbor to the recipient 
population. The protocol for this assay is very similar to the protocol described for cell aggregation 
assay.  After the donor cells (OG1RF, OG1RF∆gelE, OG1RF∆gelE∆opp, OG1RF∆gelE∆opp2 
and OG1RF∆gelE∆opp∆opp2) harboring pCF10, pAM714 or pAM378 were grown along with the 
recipient OG1SSp cells to induce broth mating, the cultures (Transconjugants and Donors) were 
track diluted onto THB plates containing spectinomycin-tetracycline or spectinomycin-
erythromycin to select for transconjugants.  The transconjugation efficiency for these reactions is 
shown in Table 3-4.  Consistent with a previous report (36), the gelE deletion mutant was slightly 
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better in mating efficiency as the absence of gelatinase enhanced mating efficiency by ~ 0.5 log10, 
efficiency of OG1RF∆gelE∆opp1 was attenuated by 2 logs in all 3 pheromone responsive plasmids 
 
Figure 3-4: Transconjugation assay performed using OG1RF, OG1RFΔgelE, OG1RFΔgelEΔopp1, 
OG1RFΔgelEΔopp2 and OG1RFΔgelE Δopp1Δopp2 harboring A) pCF10 B) pAM714 and C) pAM378 as 
the donors and OG1SSp as the recipient. CFU/ml represent the number of colony forming units of the 
transconjugants.  *, significant difference (P < 0.05) relative to wild-type OG1RF. Experiments were 
performed in triplicate, and error bars represent standard errors of the means (SEM). 
 
systems compared to OG1RF and OG1RF∆gelE donor cells suggesting that the Opp1 complex is 




Table 3-4: Transconjugation Efficiency: No. of Transconjugants/ No. of Donors 
 
Interestingly, OG1RF∆gelE∆opp2 displayed a very modest attenuation (~1.0 log attenuation 
compared to OG1RF and OG1RF∆gelE donor cells) suggesting that the Opp2 complex may play  
a less significant role in the import of the mating peptides compared to the Opp1 system under the 
conditions tested.  OG1RF∆gelE∆opp1∆opp2 however was highly attenuated as a donor and 
displayed a ~4-5 log attenuation in mating efficiency compared to OG1RF and OG1RF∆gelE 
donor cells suggesting that the absence of both the oligopeptide permease complexes prevents the 
donor cells from responding efficiently to the recipient derived peptide pheromones (Fig. 3-4.; 
Table 3-4). 
 
Deletion of Opp complexes results in biofilm defects: 
Biofilm formation is a coordinated process that involves extensive cell-cell communication for the 
formation of highly ordered three dimensional structures. A growing number of studies have 





          pCF10 system 
 
           pAM714 system 
 




2.979 X 10-1 ± 0.642 X 10-1 
 
  2.963 X 10-1 ± 1.213 X 10-1 
 




5.965 X 10-1 ± 2.186 X 10-1 
 
  7.109 X 10-1 ± 1.389 X 10-1 
 




4.221 X 10-4 ± 2.732 X 10-4 
 
  3.923 X 10-4 ± 1.067 X 10-4 
 




2.502 X 10-2 ± 1.279 X 10-2 
 
  1.701 X 10-2 ± 1.025 X 10-2 
 





3.723 X 10-6 ± 0.889 X 10-6 
 
  3.4123 X 10-6 ± 1.027 X 10-6 
 
 5.621 X 10-6 ± 2.324 X 10-6 
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Opp complexes contributed significantly to the import of peptide sex pheromones, we 
hypothesized that cells that lack these complexes will not be able to respond to important cell  
 
Figure 5: A) Confocal microscopy biofilm analysis was performed on 1-day old biofilms formed byV583, 
V583Δopp1, V583Δopp2 and V583Δopp1Δopp2. All the strains contain the plasmid pMV158GFP, which 
provides constitutive expression of GFP. B) Bacterial growth curves.  E. faecalis strains V583, V583Δopp1, 
V583Δopp2 and V583Δopp1Δopp2 were grown under static conditions in Tryptic Soy Broth (TSB) at 37°C 
and samples were analyzed by optical density absorbance (OD600). 
 
signaling peptide pheromones during biofilm formation and will exhibit biofilm defects. To test 
this hypothesis, we tested the opp deletion mutants in the V583 genetic background that also 
constitutively express GFP using the plasmid pMV158-GFP (26). The resulting strains 
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V583∆opp1(pMV158GFP), V583∆opp2(pMV158GFP), V583∆opp1∆opp2(pMV158GFP) along 
with wild-type control V583(pMV158GFP) were used in the confocal biofilm assays. After 24hrs, 
V583∆opp1(pMV158GFP) and V583∆opp2(pMV158GFP) formed comparable biofilms to that of 
V583(pMV158GFP), whereas V583∆opp1∆opp2 (pMV158GFP) displayed a significant biofilm 
defect compared to the wild-type suggesting that the E. faecalis is unable to form confluent 
biofilms in the absence of both the Opp complexes (Fig. 3-5A). The biomass and average thickness 
of these biofilms were quantified by COMSTAT analysis (40) and the double opp mutant showed 
a 4.8-fold reduction in biomass and a 3.6-fold reduction in average biofilm thickness compared to 
the parental strain V583, whereas the individual opp deletions were not significantly different from 
the parental strain (Table 3-5).  
 
Strains     Biomass (µm3/ µm2)  Average Thickness (µm) 
V583       2.07 ± 0.783       2.67 ± 0.237 
V583Δopp1       2.34 ± 0.334       2.73 ± 0.642 
V583Δopp2       2.15 ± 0.248       2.45 ± 0.317 
V583Δopp1Δopp2       0.43 ± 0.169       0.73 ± 0.133 
 
Table 3-5: COMSTAT analysis of 1-day old biofilms 
  
Several studies have shown that the deletion of oligopeptide permeases affects the ability of those 
mutant microorganisms to grow in enriched media like TSB (41), peptide rich media (42, 43) or 
in in-vivo abscesses (41). We wanted to determine whether the biofilm defect was attributed to 
poor growth in TSB (biofilm medium).  V583, V583∆opp1, V583∆opp2 and V583∆opp1∆opp2 
were grown overnight in TSB at 37°C and were back diluted 1:100 in fresh TSB and growth was 
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monitored until late stationary phase (12 hrs.). None of the 3 deletion mutants displayed any 
significant growth defect compared to the wild-type under these growth conditions (Fig. 3-5B).   
 
The transport of the toxic peptide bialaphos requires the Opp complex in several gram-positive 
species including Bacillus subtilis, Streptococcus pyogenes and Listeria monocytogenes as the 
deletion of the opp complex genes in these bacteria renders the cells refractory to the toxic effects 
of bialaphos, a tripeptide antibiotic that is known to enter cells via oligopeptide permeases (44-
46). However, when we tested the sensitivity of V583, V583Δopp1, V583Δopp1 and 
V583Δopp1Δopp1 mutant strains against this toxic peptide, we did not observe any phenotypic 
differences even when bialaphos was used at 1-10 mM concentrations, suggesting that E. faecalis 
may have an altered intracellular target, rendering them resistant to bialaphos independent of a 
functional oligopeptide permease.   
 
Deletion of peptide pheromones transporters results in attenuated virulence in a C. elegans 
infection model:  
We recently showed that deletion of the peptide pheromone transporter (PptAB) that is essential 
for the secretion (export) of the peptide sex pheromones in E. faecalis results in a biofilm defect 
(17). Since the deletion of both the opp complexes also resulted in attenuated biofilm formation, 
we wanted to determine whether the absence of these peptide transporters affected the virulence 
of E. faecalis due to the inability of the transporter mutants to form biofilms. We used the C. 
elegans model of infection to address these questions since this model has been used by others to 
identify virulence factors in E. faecalis (47, 48).  We tested V583, V583ΔpptAB, V583Δopp, 
V583Δopp2 and V583ΔoppΔopp2 in this model and the results are shown in figure 6. While the 
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V583Δopp2 strain phenocopied the wild-type strain V583, the V583Δopp1 was significantly 
attenuated in C. elegans killing compared to V583 (P < 0.05; P=0.021), Log-Rank (Mantle-Cox 
test)) (Fig. 3-6A).  
                                 
 
Figure 6: C. elegans killing assay. V583, V583ΔpptAB, V583Δopp1, V583Δopp2 and V583Δopp1Δopp2 
were spotted on BHI agar and incubated at 37°C to obtain bacterial lawns. C. elegans strain N2 worms were 
transferred to these plates and were monitored for survival every 24 hrs. Survival curves were plotted using 
GraphPad Prism (San Diego, CA) and statistical analysis was done using Log-Rank (Mantle-Cox) test. ** 
and ***, significant difference (P < 0.05 and P < 0.005) relative to wild-type V583. Experiments were 
performed in triplicates. 
 
Interestingly, V583ΔpptAB and V583Δopp1Δopp2 were highly attenuated in the C. elegans killing 
assay compared to the wild-type strain V583 (P < 0.01; P = 0.0009), Log-Rank (Mantle-Cox test)) 




In this study, we have identified and characterized a previously unidentified oligopeptide permease 
complex in the core genome of E. faecalis strain V583. Oligopeptide permeases (Opp) are an 
important class of membrane transporters that are known to play distinct roles in bacteria. They 
are predominantly involved in the uptake of short peptides for nutrient acquisition, but are also 
emerging as important mediators of gene regulation by contributing to the import of peptide 
pheromones (39, 49, 50). In this study, we have demonstrated that a second, previously 
uncharacterized Opp complex is encoded by the V583 core genome (EF_3110-EF_3107). We took 
advantage of the fact that the cOB1 peptide sex pheromone inhibits the growth of V583.  Using 
synthetic cOB1 pheromone, we showed that only the deletion of both the opp complexes renders 
E. faecalis V583 refractory to the inhibitory effects of cOB1. This suggests that in the absence of 
one Opp complex, the other could be playing a compensatory role.  We have also shown using 3 
independent pheromone responsive plasmid systems that the donor cells respond very poorly to 
the peptide pheromones secreted by recipients in the absence of both the Opp complexes, which 
is indicative of overlapping roles played by these chromosomally encoded oligopeptide permeases.  
Opps play an important role in the transport of peptide pheromones in several different gram-
positive species. B. subtilis possesses two oligopeptide permease systems (Opp and App) that play 
overlapping roles in peptide transport (46)  including the importation of Phr peptides (51) which 
in turn inhibit the activity of Rap phosphatases responsible for dephosphorylating Spo0F, a 
component of the phosphorelay involved in the phosphorylation of Spo0A, a master regulator in 
the sporulation response.  Rap phosphatases also play a role in regulating competence development 
in B. subtilis and opp mutants also   The activity of the neutral protease regulator, NprR, is also 
regulated by a small peptide termed NprX (46, 52, 53). In Bacillus cereus, the PapR peptide that 
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regulates gene expression via the PlcR transcriptional regulator is imported into the cell via an Opp 
complex and in Streptococcus pyogenes, the SHP peptides are imported via an Opp complex and 
these peptides regulate gene expression by interacting with the Rgg family of transcriptional 
regulators (39, 54).  Interestingly, both B. subtilis and S. pyogenes are susceptible to the toxic 
tripeptide, bialaphos, and the deletion of the Opp complexes in these bacteria confers resistance to 
this peptide indicative of the involvement of the Opp complex in the transport of bialaphos (45, 
46). However, the E. faecalis strain V583 did not display any susceptibility at 1-10 mM 
concentrations towards bialaphos and the deletion of the Opp complexes did not alter this 
phenotype suggesting that E. faecalis may be more inherently resistant to this tripeptide antibiotic 
through an unknown mechanism.  
Increasing evidence in gram-positive bacteria suggests that short linear peptides are used as 
quorum-sensing signals and require oligopeptide permeases for uptake, and that such signals are 
perceived by gene regulators that bind the imported peptides (39, 54-61).  A recent study by Chang 
et al. (39) showed that biofilm formation in Streptococcus pyogenes is regulated by Rgg 
transcriptional regulators that bind to short hydrophobic peptides (SHP) which are imported into 
the cells via the Opp complex. These short hydrophobic peptides are not derived from lipoprotein 
precursors unlike the well characterized enterococcal pheromones (cCF10, cAD1, cOB1) but are 
independent genes located adjacent to, but divergent from the cognate Rgg encoding genes. Our 
laboratory recently demonstrated that the deletion of the peptide pheromone transporter (PptAB) 
that secretes hydrophobic peptide pheromones in strain V583 resulted in attenuated biofilm defects 
(17). Interestingly, our data from this study indicate that the mutant strains that lack both the Opp 
systems are also unable to form confluent biofilms.  Biofilm formation is an important pre-requisite 
for E. faecalis virulence since most infections caused by this bacterium are biofilm-associated (62, 
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63).  When V583∆opp1∆opp2 and V583∆pptAB strains were tested in the C. elegans infection 
model along with the opp single deletions mutants, V583∆pptAB and V583∆opp∆opp2 were 
significantly attenuated in C. elegans killing compared to the wild-type.  
 
 
Figure 3-7: A) Pheromone-mediated biofilm regulation in E. faecalis. 1) Lipoprotein-derived peptide 
pheromones and/or peptides derived from putative short coding sequences (58) are  exported via the Peptide 
Pheromone Transporter (PptAB) (17).  2) Secreted peptides are bound by OppA or its homologs with high 
affinity 3) and actively imported into the cell via the oligopeptide permease complex 4) where the peptide(s) 
interact with plasmid or chromosomally encoded RNPP family members in E. faecalis to regulate the 
expression of biofilm important genes. B) Involvement of Opp systems in pheromone mediated 
conjugation. 1) Peptide pheromones produced by recipient E. faecalis populations are sensed by the OppA 
homologs (PrgZ/TraC) encoded by the cognate pheromone-responsive plasmids and are imported into the 
donor cells via the chromosomally encoded oligopeptide permeases. 2) This alleviates the PrgX/TraA-
mediated repression of conjugative functions resulting in activation of pheromone-responsive genes 3) with 
subsequent plasmid transfer to the recipient cells. 4) Aggregation substance, a pheromone-responsive gene 




It is important to note that strains lacking the peptide pheromone transporter (PptAB) or both the 
Opp complexes (V583∆opp1∆opp2) exhibit biofilm defects and this could possibly explain the 
attenuated killing phenotype that these mutants exhibit in the C. elegans model. A possible model 
for pheromone-mediated regulation of biofilm formation in E. faecalis is depicted in Figure 7.  It 
is possible that enterococcal pheromones (lipoprotein-derived and/or derived from putative short 
coding sequences (58) interact with RNPP protein family homologs (53, 59) present in E. faecalis 
to regulate the expression of genes involved in conjugal plasmid transfer as well as biofilm 
development.  The RNPP family consists of Rap/NprR/PlcR/PrgX proteins that share an amino-
terminal DNA binding domain along with a carboxy-terminal possessing tetratricopeptide repeats 
thought to be involved in binding small peptides (53). PrgX, a prototype-member of the RNPP 
family is encoded on the pCF10 pheromone-responsive plasmid in E. faecalis and represses 
conjugative functions including the intercellular adhesion, aggregation substance.  Upon sensing 
the pheromone cCF10, repression by PrgX is alleviated and expression of aggregation substance 
allows for intercellular aggregation (13).  Expression of aggregation substance is known to 
enhance colonization of explanted heart valves (60) as well as increasing vegetation size in a rabbit 
model of endocarditis (61).  In addition to PrgX homologues encoded on the pheromone-
responsive plasmids pTEF1 (EFA_0004) and pTEF2 (EFB_0005), E. faecalis V583 is also 
predicted to possess several chromosomally-encoded RNPP homologs [EF_0073, EF_1224, 
EF_1316, EF_1599 and EF_2687 (ElrR)] (59). Ibrahim et al. in 2007 identified several short 
hydrophobic peptide encoding genes in E. faecalis strain V583 using bioinformatic analysis and 
some of these genes are located adjacent to the genetic locus of the aforementioned RNPP family 
proteins (58). It is conceivable that these short hydrophobic peptides are transported by PptAB and 
then reimported by the Opp complexes to interact with these RNPP family proteins to regulate 
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gene expression in E. faecalis. Characterizing these E. faecalis RNPP homologs and identifying a 
role for their cognate peptides is the current focus of ongoing studies in the laboratory.  
Recent studies have demonstrated a role for the oligopeptide permease complex in virulence in 
several pathogenic bacteria including Mycobacterium tuberculosis, S. pyogenes and Borrelia 
burgdorferi (62-64). To our knowledge, this is the first study examining the contribution of E. 
faecalis Opps in biofilm formation and virulence using the nematode infection model.  Of the two 
Opps, Opp1 appeared to exhibit a greater contribution to pathogenesis in the nematode infection 
model, as well as pheromone uptake for conjugal mating.  However, deletion of both Opps was 
required to achieve the strong attenuation in biofilm development.  The question remains why E. 
faecalis acquired two Opp systems.  There may be substrates to which one Opp is better tailored 
to import.  It is noteworthy that recent transcriptome analyses comparing growth in serum and 
urine for host cues to infection identified the second Opp system [EF_3106-3110] as being 
significantly induced (4-6 fold) compared to growth in laboratory medium (65, 66), suggesting 
that Opp2 may have more relevancy in mammalian infection settings.   
E. faecalis in recent years has surfaced as one of the leading causes of nosocomial infection due 
to its ability to survive antibiotic treatments and cause persistent infections in a host (57, 67).  In 
the dawn of the post-antibiotic era, it is of paramount importance to identify novel candidate genes 
for targeted therapeutic intervention and oligopeptide permeases represent a viable target for 
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Eep CONFERS LYSOZYME RESISTANCE TO Enterococcus faecalis VIA THE 












Enterococcus faecalis is a commensal bacterium found in the gastro-intestinal tract of most 
mammals including humans and is one of the leading causes of nosocomial infections. One of the 
hallmarks of E. faecalis pathogenesis is its unusual ability to tolerate high concentrations of 
lysozyme, which is an important innate immune component of the host. Previous studies have 
shown that the presence of lysozyme leads to the activation of SigV, an ECF sigma factor in E. 
faecalis and the deletion of sigV increases the susceptibility of the bacterium towards lysozyme. 
Here we describe the contribution of Eep, a membrane-bound zinc metalloprotease, to the 
activation of SigV under lysozome stress by its effects on the stability of the anti-sigma factor 
RsiV.  We demonstrate that the ∆eep mutant phenocopies the ∆sigV mutant in lysozyme, heat, 
ethanol and acid stress susceptibility. We also show using an immunoblot analysis that in an eep 
deletion mutant, the anti-sigma factor RsiV is only partially degraded after lysozyme exposure, 
suggesting that RsiV is processed by unknown protease(s) prior to the action of Eep. An additional 
observation is that the deletion of rsiV which results in constitutive SigV expression leads to 
chaining of cells, suggesting that SigV might be involved in regulating cell-wall modifying 
enzymes important in cell wall turnover. We also demonstrate that in the absence of eep or sigV, 
enterococci bind significantly more lysozyme providing a plausible explanation for the increased 







Enterococcus faecalis is a commensal organism present in the mammalian gastrointestinal 
system (1). Over the past few decades, E. faecalis has arisen as one of the leading causes of 
nosocomial infection (2). Its role as an opportunistic pathogen is strengthened by harboring mobile 
genetic elements, which are often responsible for conferring resistance to a broad range of 
antibiotics including vancomycin (3).  In addition, E. faecalis is known to demonstrate a 
heightened ability to survive in the presence of environmental stress factors such as increased 
temperature, acidic pH, and oxidative stress (4). In addition to persistence in the presence of the 
aforementioned stress factors, previous studies have shown that E. faecalis is also highly resistant 
to lysozyme (5). This high-level resistance to lysozyme (> 62 mg/ml) is predominantly attributed 
to the ECF sigma factor SigV (5).  ECF sigma factors are sequestered by membrane-bound anti-
sigma factors and rendered inactive in the absence of a given external stress.  Under stress-inducing 
conditions the anti-sigma factors are degraded by membrane and cytosolic proteases leading to the 
activation of ECF sigma factors in a process referred to as a regulated intramembrane proteolysis 
(RIP) (6).   
RIP has been shown to play an important role in multiple transmembrane signaling 
processes associated with increased virulence and environmental fitness (7).  In Escherichia coli, 
DegS, a site-1 protease and RseP, a site-2 protease, have been shown to degrade the anti-sigma 
factor RseA in response to environmental stress, thus mediating the release of SigE (8).  A similar 
mechanism is displayed by Bacillus subtilis in which PrsW and RasP are the site-1 and site-2 
proteases respectively (9). In E. faecalis,  neither site-1 nor site-2 proteases involved in the 
processing of extracytoplasmic function (ECF) sigma factors have been identified to date.  The 
release of SigV from RsiV is thought to require proteolytic cleavage of RsiV.  A candidate site-2 
116 
protease was predicted to be Eep, as it possesses many of the characteristics of membrane localized 
site-2 proteases (10).  We hypothesized that Eep would play an important role in the regulated 
intramembrane proteolysis of RsiV leading to the activation of SigV. Here we show that Eep is 
essential for the complete degradation of RsiV which in turn is essential for the activation of SigV. 
Furthermore, the deletion of eep retards the ability of the SigV regulon to respond to lysozyme and 
several other stresses, which likely explains the significant contribution that Eep plays during 
infection (11).   
 
MATERIALS AND METHODS: 
Bacterial Strains, Plasmids & Growth Conditions: 
Pertinent bacterial strains and plasmids used in the current study are listed in Table 4-1 and Table 
4-2.  Strains were cultured in Todd-Hewitt broth (THB) and grown at 37˚C unless otherwise 
indicated.  Escherichia coli ElectroTen-Blue (Stratagene, La Jolla, CA) and E. faecalis V583 were 
used for maintenance and propagation of plasmid constructs.  ElectroTen-Blue clones were 
cultured aerobically in Luria-Bertani (LB) broth at 37˚C and E. faecalis V583 and FA2-2 derived 
strains were cultured in THB at 37˚C.  Antibiotics for selection included chloramphenicol at 10 µg 
ml-1 and spectinomycin at 150 µg ml-1, for E. coli and chloramphenicol at 15 µg ml-1 and 
spectinomycin at 500 µg ml-1, for E. faecalis.  Transformation of plasmids into E. faecalis was 





Table 4-1: Bacterial strains used in this study 
 
Strain Genotype or description Reference 
V583 Parental Strain (48)  
FA2-2 Parental Strain (14) 
SV03 V583∆eep This Study 
SV05 FA2-2∆eep This Study 
SV07 V583∆sigV This Study 
SV08 SV03(pSV24) complement of eep mutant, Specr This Study 
SV17 SV03(pSV04) empty vector control, Specr This Study 
SV09 V583(pSV23) GFP-RsiV fusion,  Specr This Study 
SV10 SV03(pSV23) GFP-RsiV fusion, Specr This Study 
SV11 V583(pSV14) sigV promoter fusion to lacZ,  Specr This Study 
SV12 SV03(pSV14) sigV promoter fusion to lacZ,  Specr This Study 
SV13 SV07(pSV14) sigV promoter fusion to lacZ,  Specr This Study 
SV14 V583∆rsiV This Study 
SV15 SV14(pSV14) sigV promoter fusion to lacZ,  Specr This Study 
WM01 FA2-2∆sigV This Study 
WM02 V583Δeep∆rsiV   This Study 
VI50 V583∆pgdA This Study 
VI60 V583(pVI16) pgdA promoter fusion to lacZ,  Specr This Study 
VI61 SV03(pVI16) pgdA promoter fusion to lacZ,  Specr This Study 
VI62 SV07(pVI16) pgdA promoter fusion to lacZ,  Specr This Study 
SV16 SV14 (pVI16) pgdA promoter fusion to lacZ,  Specr This Study 
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Table 4-2: Plasmids used in this study. 
 
Plasmid Description Reference 
pLT06 Deletion vector; chloramphenicol resistance (13) 
 
pSV03 pLT06 containing engineered eep deletion (~2-kb EcoRI/PstI 
fragment) 
This Study 
   
pSV15 pLT06 containing engineered sigV deletion (~2-kb EcoRI/PstI 
fragment) 
This Study 
   
pML28 pAT28 derivative containing the aph promoter  (18) 
   
pSV17 pML28 derivative containing rsiV with an N-terminal flag tag This Study 
   
pSV23 pSV17 derivative containing a gfp-rsiV fusion under the 








A derivative of pTCVLac-Spec in which the erythromycin 
methylase gene was removed by AflII digestion, Specr 
 
This Study 
   
pMV158GFP gfp containing plasmid, Tetr  (19) 
   
pSV04 A derivative of pTCVLac-Spec in which the lacZ and 
erythromycin methylase genes were removed by SalI 
digestion, Specr 
This Study 
   
pSV24 pSV04  containing full length eep under the native eep 
promoter 
This Study 
   
pVI15 pLT06 containing engineered pgdA deletion (~2-kb 
EcoRI/PstI fragment) 
This Study 
   
pWM07 pLT06 containing engineered rsiV deletion (~2-kb 
BamHI/PstI fragment) 
This Study 
   
pSV14 pKS12A containing sigV promoter region (1234-bp 
EcoRI/BamHI fragment) 
This Study 
   




Construction of E. faecalis in-frame deletion mutants: 
 
Table 4-3: Primers used in the study. 
 







Eep 5’ GAGAGAATTCACTTTCATGGTAGCACATGTC 































In frame deletions of sigV, rsiV, pgdA and eep individually and the double deletion mutant of rsiV 
and  eep in E. faecalis were done using plasmids derived from pLT06 (13), an E. coli enterococcal 
temperature-sensitive cloning vector that possesses selectable and counterselectable markers that 
aid in the selection of mutants containing the targeted deletions. The primers used for all the 
deletions are listed in Table 4-3. Flanking regions (~1Kb) from both the 5’ and 3’ ends of sigV, 
rsiV, pgdA and eep were PCR amplified by using the primers listed in Table 4-3.  
 
For the construction of the pSV03 plasmid (eep deletion) the primers EepP1 and EepP2 were used 
to amplify the ~1Kb region flanking the 5’ end of eep on the V583 genome. Primers EepP3 and 
EepP4 were used to amplify the ~1Kb region flanking the 3’ end of the eep region. The EepP1 and 
EepP2 primers contained EcoRI and XbaI sites, respectively and EepP3 and EepP4 primers 
contained XbaI and SphI sites, respectively. Each product was cut with the respective restriction 
enzymes, and ligated to pLT06 cut with EcoRI and SphI prior to electroporation into E. coli 
ElectroTen-Blue cells. Confirmation of the appropriate clones was performed by restriction digest 
and sequence analysis.  An analogous approach was used for the construction of pSV15 (sigV 
deletion); pWM07 (rsiV deletion) and pVI15 (pgdA deletion). Purified plasmids from E. coli cells 
were electroporated into electrocompetent V583 cells.  SV03 [V583∆eep], SV07 [V583∆sigV], 
SV14 [V583∆rsiV], and VI50 [V583ΔpgdA] were generated following the protocol as previously 
described (13). The eep deletion allele was designed such that the first 2 and the last 7 codons 
remained (98% deleted).  For sigV, the deletion allele consisted of the initial 6 and last 7 codons 
(92% deleted).  The deletion for rsiV included the first 6 and last 7 codons (96% deleted), while 
the pgdA deletion allele possessed the first 3 and the last codon (99% deleted).  To create the 
double deletion of rsiV and eep, electrocompetent SV03 cells were transformed with pWM07, and 
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the deletion mutant designated as WM02 [V583∆eep∆rsiV] was similarly created (13).  To rule 
out strain differences associated with V583, we also created deletion mutants for eep and sigV in 
the FA2-2 (14) strain background.  FA2-2 is a plasmid-free strain derived from the non-hemolytic, 
non-proteolytic clinical isolate JH2 (15).  FA2-2 was transformed with pSV03 (Δeep) and pSV15 
(ΔsigV) and following plasmid integration and excision events, the deletion strains SV05 [FA2-
2Δeep] and WM01 [FA2-2ΔsigV] were created.  
Complementation of eep deletion mutant: 
An in-frame eep deletion in E. faecalis V583 was complemented with full length eep under the 
control of the native eep promoter region in a pSV04 vector background and was denoted as 
pSV24. The eep complement amplified from the V583 genome with primers Eep5’ and Eep3’ 
(Table 3) and subsequently inserted as an EcoRI/BamHI fragment into pSV04 cut with 
EcoRI/BamHI.  To construct pSV04, plasmid pTCVLac-Spec (16) was digested with SalI and self-
ligated to release the SalI fragment containing the lacZ gene.  Plasmid pSV24 was transformed 
into SV03 [V583Δeep], and phenotypic complementation was confirmed by a lysozyme minimum 
inhibitory concentration (MIC) assay.  
MIC assay for determining lysozyme sensitivity: 
 The MIC of lysozyme against the strains V583, SV03 [V583Δeep], SV07 [V583ΔsigV], SV14 
[V583ΔrsiV], VI50 [V583ΔpgdA]; WM02 [V583ΔeepΔrsiV], SV08 [SV03 with Eep 
complementation vector], along with FA2-2, and its isogenic derivatives SV05 [FA2-2Δeep] and 
WM01 [FA2-2ΔsigV] were determined by two-fold serial dilution of a 250 mg/ml lysozyme stock 
in LB broth to achieve a series of lysozyme concentrations ranging from 0 mg/ml to 62.5mg/ml in 
a 96 well microtiter plate.  Briefly, the strains were grown as standing cultures at 37°C in LB broth 
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overnight to reach stationary phase.  These overnight cultures (~ 108 CFU/ml) were diluted 1:100 
in fresh LB and then 100 μl was added to 100 μl of the LB containing serially diluted lysozyme, 
such that each well contained an initial inoculum of ~ 105 CFU.  The plate was then incubated at 
37˚C for 24 hours before the results were documented. SV08 [SV03 with eep complementation 
vector, pSV24] and SV17 [SV03 with empty vector pSV04] were grown overnight in the presence 
of 500 µg ml-1 spectinomycin for plasmid maintenance.  
Settling and Chaining Assays: 
V583, SV14 [V583ΔrsiV], SV03 [V583Δeep], SV07 [V583ΔsigV] and WM02 [ΔeepΔrsiV] were 
grown in THB overnight at 37°C with and without lysozyme at 1 mg/ml and photographed to 
observe the settling phenotype, which is noted by growth of the bacterium at the bottom of the test 
tube.  The upper layer of the growth medium becomes transparent as cells settle and grow on the 
bottom of the tube.  Liquid cultures from the respective strains were also Gram-stained and 
photographed to observe chaining (Nikon Eclipse 80i; 100X Oil Immersion Objective). 
Miller assay using strains containing PsigV-lacZ and PpgdA-lacZ reporter fusion plasmids: 
To investigate the transcriptional activity of known SigV-dependent promoters, we created sigV 
and pgdA promoter fusions to a lacZ reporter in plasmid pKS12A, a derivative of pTCV-Lac Spec 
(16) , in which a small AflII fragment containing the erythromycin methylase gene was deleted.  
pSV14 (PsigV-lacZ) and pVI16 (PpgdA-lacZ) were created by amplifying the promoter regions of 
sigV with primers SigVP1 and SigV2 and the pgdA promoter with primers PgdAP1 and PgdAP2, 
respectively. The promoter regions for both these plasmids were defined based on the known 
transcriptional start sites for both sigV and pgdA (4).  These promoters contain the consensus SigV 
promoter recognition sequence (5’ TGAAAC-N17-CGTC 3’), and we included an additional ~ 1 
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kb region (1188 bp for sigV and 914 bp for pgdA) upstream of the transcriptional start site to 
provide additional genetic context for the promoter fusion studies.   Primers were engineered with 
EcoRI and BamHI restriction sites to facilitate cloning into pKS12A.  Resulting vectors pSV14 
and pVI16 were transformed into V583, SV03 [V583Δeep], SV07 [V583ΔsigV] and SV14 
[V583ΔrsiV] strains. The new strains SV11 [V583 (pSV14)], SV12 [SV03 (pSV14)], SV13 [SV07 
(pSV14)], SV15 [SV14 (pSV14), VI60 [V583 (pVI16)], VI61 [SV03 (pVI16)], VI62 [SV07 
(pVI16)] and SV16 [SV14 (pVI16)] were grown overnight in THB containing 500 µg ml-1 of 
spectinomycin at 37°C for plasmid maintenance. The overnight cultures were diluted 1:100 in 
sterile THB containing spectinomycin and cultured to reach an OD600 of 0.5.  At this point, cells 
were induced with lysozyme at a concentration of 1mg/ml for 30 minutes. The cultures were then 
processed to evaluate β-galactosidase activity according to the modified Miller assay as described 
(17).  To establish a dose response curve to induction by lysozyme, SV11 [V583 (pSV14)] was 
exposed to increasing concentrations of lysozyme (0, 1, 10, 100 and 1000 μg/ml) for 30 minutes 
prior to assaying for Beta-galactosidase activity. All assays were repeated three times and 
statistical significance was determined using 1way-ANOVA. 
Temperature, Ethanol and Acid Challenge Assays: 
In order to determine the survival of V583, SV03, SV14, WM02 and SV07 under different stress 
conditions, the protocol described by Benachour et.al (4) was followed. The strains were grown in 
5 ml THB medium at 37°C to an optical density OD600 of 0.5 (mid-exponential growth phase). 
Bacteria were harvested by centrifugation, resuspended in 5 ml of fresh medium, and then exposed 
to the following stresses: (i) for high-temperature heat shock, the cultures were transferred to 62°C 
(ii) for ethanol shock; ethanol was added to a final concentration of 22% (vol/vol) (iii) for acid 
shock, the pH was adjusted to 3.2 with 85% lactic acid.  Cells were exposed to stress conditions 
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and surviving bacterial numbers were quantified by plate counting at 0, 1 and 2 hours after stress 
initiation.  Assays were repeated three times and statistical significance was established using 2 
way-ANOVA in the GraphPad 5 software package (Prism, San Diego, CA) Percent survival shown 
in the graphs represents the ratio of the number of viable cells after exposure to stress to the number 
of cells at time zero prior to challenge. 
Coomassie Brilliant Blue (CBB) staining of whole cell lysates: 
Whole cell extracts of V583, SV03 and SV07 were prepared by growing strains in THB to an 
OD600 of 0.7-0.8.  Lysozyme at a concentration of 1mg/ml was added to the cultures for 2 hrs and 
the cultures were centrifuged and the pellet was washed twice with 1ml of TE Buffer (pH 8.0). 
These 1ml suspensions were lysed using a mini bead-beater (BioSpec Products, Bartlesville, OK) 
and the addition of a 500 μl volume of 0.1 mm zirconia beads with a speed setting set at 4800 rpm 
for 1 minute. After brief centrifugation to settle the beads, a 5X-SDS loading dye was added to the 
whole cell lysate and samples were boiled at 100°C for ten minutes. To normalize the amount of 
protein loaded onto the polyacrylamide gel, the whole cell lysates were also subjected to Bradford 
protein assay to determine protein amounts in each sample. The same amount of protein was loaded 
into each well and the samples were run at 200V for an hour and were then subjected to CBB 
staining. Whole cell lysates from cultures without lysozyme added and purified lysozyme protein 
were used as controls. 
Immunoblotting to detect RsiV degradation: 
Plasmid pSV23 expresses the GFP-RsiV fusion protein and was constructed in the following 
manner. The rsiV gene was amplified from V583 genome using primers RsiV5’ and RsiV3’, which 
contained NdeI and SphI sites respectively.  In a second round of PCR, this product was amplified 
with an additional primer, designated FLAG-TAG and RsiV3’, the resulting product contained an 
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introduced BamHI site and a Flag-tag encoding sequence at the 5’ end.  This BamHI and SphI 
digested product was cloned into similarly digested pML28 (A pAT28 derivative containing an 
aph promoter) (18) to create pSV17.  We next swapped the Flag-tag for a GFP tag by digesting 
pSV17 with BamHI and NdeI. The GFP encoding region was amplified from pMV158GFP (19) 
using primers GFP-5’BamHI and GFP-3’AseI.  This PCR product was digested with BamHI and 
AseI and ligated to BamHI and NdeI digested pSV17 to obtain pSV23.  E. faecalis strains V583 
and SV03 were transformed with pSV23 to create SV09 and SV10, respectively.  Cultures of SV09 
[V583 (pSV23)] and SV10 [SV03 (pSV23)] were grown overnight in THB at 37°C and diluted 
1:100 into 10 ml of fresh THB.  Cultures were grown to an OD600 of 0.7-0.8 at which point 
lysozyme was added to a concentration of 1 mg/ml and the cultures were incubated for an 
additional 2 hrs. SV09 and SV10 cultures to which no lysozyme was added were used as negative 
controls. All four cultures were centrifuged and the pellets were resuspended in 1ml TE buffer (pH 
8.0). Protease inhibitors and EDTA were added to these suspensions and subjected to mini-bead 
beating as described. The lysates were analyzed on a 10% SDS-PAGE gel.  Following 
electrophoresis, samples were electrotransferred to a PVDF membrane and blotted with Rabbit 
anti-GFP primary antibody (Cell Signaling Technology, Inc.) and anti-rabbit HRP conjugated 2° 
antibody (Sigma Aldrich). 
 
RESULTS: 
Deletion of eep renders E. faecalis more susceptible to lysozyme: 
To test whether an eep deletion mutant showed increased susceptibility towards lysozyme when 
compared to the wild-type strain, we determined the lysozyme MIC for V583, SV03 and SV08 
(eep complement).  The results of this assay are shown in Table 4-4.   The increased susceptibility 
of the eep mutant paralleled that of the sigV mutant, as both displayed MIC values at 5 mg/ml 
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compared to the > 62 mg/ml for V583.  When the eep gene was complemented back into the eep 
deletion mutant using a low-copy plasmid, the complement strain behaved similar to the wild-type  
 
Strain MIC (mg/ml) 
V583 > 62.5 
FA2-2 > 62.5 
SV03 [V583∆eep] 5.0 
SV07 [V583∆sigV] 5.0 
VI50 [V583∆pgdA] > 62.5 
SV05 [FA2-2∆eep] 5.0 
WM01 [FA2-2∆sigV] 5.0 
SV08 [SV03 (pSV24)] > 62.5 
SV17 [SV03 (pSV04)] 5.0 
WM02 [V583∆eep∆rsiV] > 62.5 
SV14 [V583∆rsiV] > 62.5 
 
Table 4-4: Minimum Inhibitory Concentration (MIC) Assay. 
 
suggesting that the phenotype we observed was Eep dependent. Consistent with previous 
observations, the pgdA deletion mutant did not show any change in lysozyme susceptibility 
compared to the wild-type (20) even though it is known to be regulated by SigV at the 
transcriptional level (4, 5).  FA2-2 and mutants lacking eep and sigV in this genetic background 
were used as controls in this study to eliminate any strain bias in the lysozyme resistance 
mechanism.  We observed a similar reduction in the MIC for the eep and sigV mutants in the FA2-
2 strain background compared to FA2-2.  Finally, as a proof of principle that Eep acts through 
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RsiV in the activation of SigV, we deleted rsiV in the eep mutant background, and showed that the 
lysozyme resistance level of this double mutant paralleled that of the wild-type (> 62.5 mg/ml).  
 
Eep is essential for the expression of sigV at the transcriptional level: 
    
Figure 4-1: Qualitative and quantitative measurement of sigV promoter and pgdA promoter activity. (A) A 
sigV-lacZ reporter strain SV11 was subjected to Miller assay analysis after treatment with increasing 
concentrations of lysozyme. (B) Spot assay of sigV-lacZ reporter strains SV11, SV12 [Δeep] and SV13 
[∆sigV] on THB plates containing 1 mg/ml lysozyme and 80 μg/ml X-gal. (C) Miller assay using LacZ 
reporter strains SV11, SV12, SV13, and SV15 [ΔrsiV] treated with and without 1 mg/ml of lysozyme. (D) 
Miller assay using pgdA-lacZ reporter strains VI60, VI61 [Δeep], VI62 [ΔsigV] and SV16 [ΔrsiV] treated 
with and without 1 mg/ml of lysozyme. * indicates significant differences (P < 0.001) relative to wild-type 
V583 in the presence of lysozyme. Experiments were performed in triplicate and the error bars represent 
standard error of the mean (SEM). 
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It is known that SigV autoregulates its own expression (4).  We constructed a sigV promoter fusion 
to lacZ to confirm these observations, and to ascertain the effect of both sigV and eep deletion on 
promoter activity. We confirmed that in wild-type cells containing the reporter plasmid (SV11) 
that the activity of the sigV promoter is induced by lysozyme in a dose dependent manner (Fig. 4-
1A).  In panel B of figure 4-1, we also demonstrated that promoter activity is dependent on a 
functional SigV as well as Eep for the response to lysozyme, as mutants in eep and sigV remain 
white in the presence of lysozyme, whereas the wild-type reporter strain turned blue on X-gal 
containing agar.  Miller assays were performed with the reporter strains to quantify the amount of 
β-galactosidase protein produced in the wild-type compared to the mutants.  SV11 produces ~80 
fold more β-galactosidase activity when compared to the eep and sigV mutants upon lysozyme 
induction (Fig. 4-1C).  We also analyzed reporter strains with the pgdA promoter fusion to lacZ, 
as expression of pgdA was previously shown to be SigV-dependent (4).  Similar results were 
observed with the Miller assay (Fig. 4-1D) in these reporter strains as both the eep and sigV mutants 
displayed reduced promoter activity compared to the parental strain.  Consistent with its known 
role as an anti-sigma factor, the deletion of rsiV resulted in constitutive expression of both SigV 
dependent promoters in the absence of lysozyme induction (Fig. 4-1C and 4-1D).    
 
Eep confers resistance to other biological stressors:   
Benachour et al. (4) showed that a sigV deletion mutant is attenuated when subjected to high 
temperature, low pH and ethanol stress conditions compared to a wild-type. Having established a 
link between Eep and SigV phenotypes for lysozyme resistance, we reasoned that other biological 
stresses known to impact a sigV mutant might also negatively affect an eep mutant compared to 
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its isogenic parent.  We therefore tested the eep and sigV mutants against a variety of biological 
stresses (heat, low pH and ethanol stress) and found that the eep mutant phenocopied a sigV mutant  
                                   
Figure 4-2: V583, SV03 [V583∆eep], SV14 [V583∆rsiV], WM02 [V583∆rsiV∆eep] and SV07 
[V583∆sigV] strains subjected to different stresses. (A) Strains were subjected to a temperature of 62˚C. 
(B) Strains were subjected to a pH of 3.2 using 85% lactic acid. (C) Strains were subjected to 22% ethanol 
treatment. Strains subjected to lactic acid stress and ethanol stress were incubated at 37 ˚C. Samples were 
drawn every hour for 2 hours and were serially diluted in sterile PBS (pH 7.4) and plated onto THB agar. 
V583∆eep and V583∆sigV were significantly attenuated compared to wild-type (P <0.001).  Experiments 
were performed in triplicate and the error bars represent standard error of the mean (SEM).  
 
in these biological aspects.  Both mutants displayed near 2-log reductions against these stresses 







restores the stress tolerance to wild-type levels, the strain harboring a double deletion of rsiV and 
eep was also tested against the aforementioned biological stresses. This strain showed tolerance to 
these stresses similar to the wild-type. As a control, rsiV deletion mutant was also used in this 
study. This suggests that deletion of Eep has a direct effect on the ability of cells to adapt to stress 
and that this phenotype could be rescued by the constitutive expression of SigV.  
 
Eep is essential for complete processing of RsiV:  
Since the strain that lacked eep phenocopied the strain that lacked sigV in all the phenotypes tested, 
our next goal was to determine the exact role of Eep in the regulated intramembrane proteolysis 
pathway leading to release of SigV. To confirm that Eep is indeed the site-2 protease, we 
constructed plasmid system wherein GFP was fused to RsiV and introduced into either the parental 
strain V583 or its isogenic eep mutant [SV03]. 
                    
Figure 4-3: Immunoblot analysis with Anti GFP antibodies. A native GFP cell lysate was used as a control.  
The unprocessed GFP-RsiV translational fusion is predicted to migrate at 62 kDa, whereas the fully 
processed GFP-RsiV migrates at the native GFP position (27 kDa).  Arrows depict incompletely processed 




Figure 4-3 demonstrates the result of this experiment wherein the plasmid bearing strains SV09 
and SV10 [Δeep] expressed the ~ 62 kDa GFP-RsiV fusion proteins in the absence of lysozyme 
stress. When lysozyme was added, RsiV in the V583 background was completely degraded by 
membrane and cytosolic proteases involved in RIP leaving only the ~27 kDa GFP protein.  The 
presence of the GFP protein after SigV activation is likely attributed to the fact that GFP lacks the 
recognition domain that is required for Clp protease degradation of target substrates (21). 
However, accumulation of two partially processed GFP-RsiV products predicted to migrate 
between 34 and 38 kDa was observed when SV10 was treated with lysozyme.   
 
eep and sigV mutants bind more lysozyme compared to the wild-type: 
 
                                                  
Figure 4-4: SDS-PAGE and Coomassie Brilliant Blue staining assay. V583, SV03 [∆eep] and SV07 
[∆sigV] were grown to an OD600 of 0.8 in the presence and absence of 1 mg/ml lysozyme. Normalized 
lysates were loaded onto a 12% polyacrylamide gel and stained with Coomassie brilliant blue dye. Purified 
lysozyme (1 μg) was added to the left of the marker lane as a control. Arrows indicate bands corresponding 
to lysozyme.  
 
132 
Enhanced susceptibility of SV03 [Δeep] and SV07 [ΔsigV] towards lysozyme led us to believe 
that these strains might be lacking some crucial mechanism that reduces the accumulation of 
lysozyme on the cell surface. The results depicted in figure 4-4 demonstrate that the sigV and eep 
mutants bind more lysozyme compared to the wild-type.  Mass-spectrometry analysis was 
performed to confirm that the protein band that was visualized primarily consisted of lysozyme 
(data not shown). This data suggests that the hyper-susceptibility of SV03 and SV07 towards 
lysozyme is likely due to the enhanced accumulation of lysozyme on the cell surface of these 
mutants. 
 
Constitutive expression of SigV results in a chaining phenotype: 
Interestingly, when the gene encoding for RsiV was deleted in the wild-type and V583 ∆eep 
genetic backgrounds, a settling phenotype of the overnight culture was observed in both strains.  
Figure 4-5 demonstrates this settling phenotype. Gram-stain revealed significant chaining in 
strains lacking RsiV compared to the wild-type, suggesting that appropriate cell wall remodeling 
is compromised by constitutive expression of SigV.  The chaining phenotype of the rsiV mutant is 
similar to that observed for an atlA mutant (22), suggesting that the cell wall modifications that 
render E. faecalis more resistant to lysozyme also perturb the activity of the major autolysin.   
 
Lysozyme induction results in a chaining phenotype: 
Because of the chaining phenotype observed in the rsiV mutant, we reasoned that exposure to 







Figure 4-5: Chaining and settling phenotypes. A) Strains indicated were grown in the presence or absence 
of 1 mg/ml lysozyme in THB overnight at 37˚C and photographed to depict the settling of the culture on 








we exposed V583, SV03 [Δeep], SV07 [ΔsigV], SV14 [ΔrsiV] and WM02 [ΔeepΔrsiV] to 1 mg/ml 
lysozyme and examined the cultures for a settling phenotype. As predicted, a settling phenotype 
was observed in the wild-type when induced with lysozyme and chaining was confirmed by Gram 
staining (Fig. 4-5).  In contrast, the eep and sigV mutants did not settle or chain in the presence of 
lysozyme.  The strains containing an rsiV deletion: SV14 [V583ΔrsiV] and WM02 [V583ΔrsiV 
Δeep] continued to chain and settle under lysozyme exposure. This suggests that activation of SigV 
leads to the chaining phenotype, and that genes under SigV control are also likely regulating the 
activity of the endogenous autolysins of E. faecalis. 
 
DISCUSSION: 
In this study, we have shown that Eep is essential for the activation of SigV which is an ECF sigma 
factor that contributes to lysozyme resistance in E. faecalis via the degradation of the anti-sigma 
factor RsiV (5). Eep belongs to a family of membrane embedded zinc metalloproteases (23). 
Previous studies have shown that Eep is involved in the processing of peptide pheromones (24-
26). To the best of our knowledge, this is the first study that demonstrates an additional role for 
Eep in the regulated intramembrane proteolysis of the anti-sigma factor RsiV leading to the 
activation of SigV.  An eep deletion mutant phenocopied a sigV deletion mutant, and was greater 
than 10-fold more susceptible to lysozyme when compared to the wild-type. Promoter fusion 
studies demonstrate that the sigV promoter is inactive in the absence of Eep. Our hypothesis that 
Eep is directly involved in the degradation of RsiV was strengthened by the observation that the 
resistance to lysozyme was restored to wild-type levels in the double mutant (ΔrsiVΔeep) strain.  
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In addition, western blot analysis revealed that Eep is required for the complete degradation of 
RsiV. It has been shown that the activation of other ECF sigma factors (6), in the presence of a 
specific stress, requires the action of membrane proteases, and the data from this current study 
confirms the rationale that Eep is one such membrane protease.  Of note, we were able to detect 
two intermediate processed forms of GFP-RsiV in the eep mutant background.  This observation 
is consistent with the requirement for multiple RsiV processing events prior to Eep cleavage.  In 
the activation of the B. subtilis SigW (ECF sigma factor), PrsW, a known site-1 protease cleaves 
RsiW (9, 27).  Upon cleavage by PrsW, further processing of RsiW occurs by an as yet to be 
identified trimming protease activity (28), and this cleavage event prepares RsiW for further 
processing by the known site-2 protease RasP.   
Data from a Coomassie-stained SDS-PAGE indicates that mutants lacking eep and sigV bind more 
lysozyme compared to the wild-type.  Previous research has shown that two cell wall modifying 
enzymes, O-Acetyltransferase (OatA) and the D-alanylation complex (DltA-D) confer resistance 
to lysozyme in B. subtilis, and that these genes are directly regulated by SigV (29). However, in 
E. faecalis it has been shown previously that individual deletion of these genes did not significantly 
affect the lysozyme susceptibility of E. faecalis, nor where the oatA and dltA-D genes shown to be 
regulated in a SigV-dependent fashion (5).  In our hands, we found that single deletions of both 
oatA and dltA-D in the V583 background did not alter the lysozyme resistance of these strains, as 
these mutants still showed growth up to 62.5 mg/ml lysozyme (data not shown).  We also examined 
a double deletion of both oatA and dltA-D in the V583 background and found that this strain was 
only marginally reduced in lysozyme resistance to ~ 32 mg/ml (data not shown), which is in 
contrast to what was observed by Le Jeune (5), wherein a double mutant of oatA and dlt was as 
sensitive to lysozyme as the sigV mutant in the JH2-2 genetic background.  Whether this difference 
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in lysozyme susceptibility can be accounted for by strain differences awaits additional study.  It is 
however noteworthy that strain JH2-2 was derived from the parent strain JH2 by nitrosoguanidine 
mutagenesis (15), and the exposure to the mutagenizing agent may account for these aberrant strain 
differences.  In contrast, the deletion of sigV rendered E. faecalis much more sensitive to lysozyme 
suggesting that SigV-dependent gene products are involved in modifying the enterococcal cell 
wall in a manner independent of peptidoglycan O-acetylation or teichoic acid D-alanylation.  
Furthermore, a study by Hébert (30) showed that a mutant in the gene encoding peptidoglycan 
deacetylase (pgdA) did not contribute to lysozyme resistance, despite the fact that this gene has 
been shown to be regulated in a SigV-dependent manner in E. faecalis (5).  
Our present studies also confirmed the absence of a link between PgdA and lysozyme resistance 
in E. faecalis V583.  PgdA does however contribute to lysozyme susceptibility in Streptococcus 
pneumoniae and virulence in animal models of infection (31-33), and recent evidence suggests 
that PgdA is linked to virulence in E. faecalis as a mutant in pgdA was attenuated in a Galleria 
mellonella infection model (20).  What role PgdA might be playing in a mammalian host during 
infection remains to be elucidated.  What is also clear from the present study and additional cited 
literature is that SigV contributes to lysozyme resistance in a unique manner and identifying the 
SigV regulon will be of paramount importance in understanding the unusual lysozyme resistance 
strategies employed by E. faecalis. Lysozyme is a naturally secreted antimicrobial agent, and is 
considered to be part of the innate immune system. It is secreted by a wide array of organisms in 
body fluids such as tears, mucus, and saliva (34-37).  A study by Frank (11) showed that Eep is 
essential for the pathogenesis of E.  faecalis in a rabbit endocarditis model. It has also been shown 
that the concentration of lactic acid is particularly high in the heart (38). One possible explanation 
as to why the virulence of an eep deletion mutant was highly attenuated in the endocarditis model 
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is that strains that lack eep are more susceptible to lactic acid stress as shown in the present study.  
Another plausible explanation is that strains lacking eep are more susceptible to lysozyme 
compared to wild-type controls, and are hence cleared more efficiently by components of the 
innate immune system (39, 40).  The same idea could potentially be applied to a urinary tract 
infection (UTI) model due to the fact that it has been shown that the body responds to urinary tract 
infection by secreting an increased amount of lysozyme (41-43).  
 It is noteworthy that a sigV mutant of E. faecalis JH2-2 was shown to be attenuated by ~ 1.5-2 
logs in bladder and kidney colonization compared to JH2-2 alone and an eep mutant of E. faecalis 
OG1RF  is attenuated in a catheter associated UTI model (5, 44).  Collectively, the available 
information to date suggests that the virulence associated with Eep is likely due to its effects on 
SigV activation.  It will be of interest to establish a link with SigV in endocarditis. It is also 
important to note that lysozyme has been shown to be an important component of the innate 
immune defense system in the gastro-intestinal tract (45). Since E. faecalis is a commensal 
bacterium which predominantly resides in the gastro-intestinal tract of mammals, it is possible that 
this bacterium has unique mechanisms that confer high levels of lysozyme resistance giving it a 
competitive edge in the gastro-intestinal tract consortium. Figure 4-6 depicts the pathway by which 
SigV is released from the anti-sigma-factor in the presence of lysozyme. Having evidence that 
supports the rationale that Eep is a site-2 protease in the regulated intramembrane proteolysis 
pathway, we postulate that both a site-1 and trimming protease act upstream of Eep cleavage to 
initiate the response to lysozyme. The biochemical analysis of the GFP-RsiV fusion in an eep 
background exposed to lysozyme suggests the existence of such proteases, as noted by the 
intermediate forms of GFP-RsiV that accumulate in the immunoblot (Fig. 4-3).  Numerous studies 
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have shown a requirement for site-1 proteases in initiating activation of ECF sigma factors (6), 
and future studies will be aimed at the identification of such a protease.   
 
Figure 4-6: A model for the regulated intramembrane proteolysis (RIP) of RsiV. A series of proteolytic 
events leads to the release and activation of SigV from its anti-sigma factor RsiV. 1) E. faecalis perceives 
a stress signal, which in this case is lysozyme. 2) This leads to the cleavage of RsiV by the putative site-1 
protease.  Based on data from figure 3 and reference (28), E. faecalis and other Gram-positives such as B. 
subtilis possess an additional putative trimming protease activity that prepares the processed RsiV for 
further proteolytic targeting by Eep  3) Eep degrades the site-1 protease processed and trimmed RsiV, 
leading to the release of SigV into the cytoplasm. 4) ClpXP cytoplasmic protease further degrades RsiV to 
release active SigV. 5) SigV initiates the binding of the RNA polymerase upstream of specific genes that 
confer lysozyme resistance.   
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Following Eep cleavage, the model predicts that RsiV is further degraded by the cytosolic protease 
complex ClpXP, as this has been shown to be essential in the activation of SigW, a known ECF 
sigma factor in Bacillus subtilis (46).  Recent work by Ellermeier’s group established that SigV 
activation in Bacillus appears to uniquely hone to lysozyme cues (47), as other cell wall and 
membrane acting agents failed to induce SigV activation.  Work by LeJeune (5) showed that nisin 
does not induce SigV activation in E. faecalis and the sigV mutant displays wild-type resistance 
to nisin, consistent with lysozyme being a key driver in SigV activation.  An unusual finding from 
our present study is that both SigV and Eep also contribute to heat, low pH and ethanol stress 
tolerance.  Attempts to use those conditions to induce SigV activation did not result in detectable 
β-galactosidase activity (data not shown), likely because the reporter protein might have been 
denatured under the tested conditions.  Conversely, data presented by Benanchour (4) corroborate 
the fact that heat, low pH and ethanol stress fail to induce SigV activation as northern blots failed 
to show an increase in sigV transcript levels following exposure to these stress inducers.  Western 
immunoblot analysis of SV09 gh2[V583 (pSV23)] lysates subjected to heat, low pH and ethanol 
stresses failed to induce the degradation of RsiV (data not shown).  This could be attributed to the 
fact that the aforementioned stresses do not strongly induce the sigV regulon but resistance towards 
these stresses could still be SigV-dependent.   We speculate that a basal level of SigV is required 
for activating genes required for tolerance to these stress conditions, and that Eep must also 
contribute to basal levels of SigV activation.  It will be of interest to determine whether the 
transcriptional profile in the wild-type and an isogenic sigV mutant differ even in the absence of 
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Enterococci are currently considered to be the second leading cause of nosocomial infections in 
the United States (1). A multitude of factors are thought to contribute to its emergence as a multi-
drug resistant pathogen. Firstly, its ability to tolerate the bactericidal action of a wide variety of 
antibiotics via several distinct mechanisms combined with the capability to acquire and 
disseminate these antibiotic resistance traits offers it a competitive advantage over other bacteria 
including several nosocomial pathogens (2-4). Secondly, enterococci are innately resistant to a 
wide variety of biotic and abiotic stresses which enables them to colonize atypical host 
environments (5-9). Finally, its ability to cause persistent infections in a host via the formation of 
biofilms on host tissues as well as artificial implant devices (e.g. catheters) may contribute to its 
recent rise as a hospital-adapted pathogen (10, 11). 
In the current study we attempted to dissect the role of three enterococcal membrane proteins 
peptide pheromone transporter (PptAB), oligopeptide permease complex (Opp1 & Opp2) and 
enhanced expression of pheromone protein (Eep) in cell-cell communication and stress adaptation. 
We took advantage of the fact that non-pathogenic E. faecalis strains like FA2-2 inhibit the growth 
of the multidrug resistant hospital lineage strains like V583 by secreting the peptide sex pheromone 
cOB1. A comprehensive transposon mutagenesis screen to identify the genes essential for this 
novel peptide killing activity led to the identification of an ABC transporter (PptAB) that was 
essential for the secretion of peptide sex pheromone, cOB1. We also demonstrated that this 
transporter (PptAB) is essential for the secretion of other well characterized peptide sex 
pheromones including cCF10, cAD1 and cAM373, suggestive of the global role played by this 
transporter in the secretion of lipoprotein derived peptide sex pheromones (Chapter 2) (12). 
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Interestingly, the deletion of pptAB in V583 resulted in a severe biofilm defect indicative of the 
potential roles played by peptide pheromones in coordinating this complex and crucial 
multicellular event. 
Peptide pheromones play a pivotal role as signaling molecules in a multitude of gram-positive 
bacteria (14, 40). Often times, these linear hydrophobic peptides are proteolytically processed and 
secreted outside the cell (12), and re-imported back into the cell via the oligopeptide permease 
complex (13, 14). Leonard et al. identified a chromosomally encoded oligopeptide permease 
complex (Opp1) that contributes for the import of the cCF10 peptide sex pheromone in E. faecalis 
(15). We recently identified a second chromosomally encoded oligopeptide permease complex 
(Opp2) in E. faecalis that along with Opp1 also contributes to the import of peptide sex 
pheromones (Chapter 3) (Varahan et al., Submitted-Journal of Bacteriology). We demonstrated 
using 3 distinct pheromone responsive plasmids systems (pCF10, pAD1 and pAM373) that both 
the Opp complexes contribute to the transport of peptide sex pheromones into the E. faecalis cells. 
Cells that do not possess both the Opp complexes (double opp deletion mutant) are unresponsive 
to recipient cell derived peptide sex pheromones. We also showed that deletion of both the opp 
complexes in tandem in strain V583 resulted in a severe biofilm defect which corroborates our 
previous finding that peptide pheromone transport is essential for E. faecalis biofilm formation 
(12). It is possible that E. faecalis is employing pheromone mediated cell signaling to coordinate 
the development of its complex three-dimensional biofilms. 
In Chapter 4, we identified the additional roles played by the membrane embedded zinc 
metalloprotease Eep in the stress resistance pathways of E. faecalis (16). Enhanced Expression of 
Pheromone protein (Eep) was discovered as a protein that is essential for the processing of 
lipoprotein derived peptide sex pheromones (17). Eep is a prototypic member of the membrane 
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embedded site-2 proteases and has an intramembrane active site. It also possess the characteristic 
PDZ domain which is present in one of the external protein loops (18, 19). We recently 
demonstrated that Eep is essential for the activation of the extracytoplasmic function (ECF) sigma 
factor, SigV, which confers high level lysozyme resistance to E. faecalis (6, 16). Under normal 
conditions, SigV is inactivated by being sequestered to the membrane by the anti-sigma factor, 
RsiV. In the presence of lysozyme RsiV is thought to undergo a conformational change which 
results in its cleavage by both Site-1 and Site-2 proteases. We demonstrated that the cleavage of 
RsiV by Eep (Site-2 protease) is essential for the complete degradation of RsiV and subsequent 
activation of SigV (16).  We also showed that Eep, along with the ECF sigma factor SigV is 
essential for E. faecalis to tolerate other biological stresses like high temperature, low pH and 
ethanol stress (16, 20). 
Interestingly, we demonstrated that the deletion of the genes encoding the peptide pheromone 
transporter (PptAB) renders E. faecalis susceptible to lysozyme. A pptAB deletion mutant 
displayed a 10-fold increased sensitivity to lysozyme compared to the wild-type strain (Fig. 5-1A). 
We took advantage of the fact that SigV binds to its own promoter and activates its own expression 
and constructed a luciferase report plasmid pKS313, wherein the sigV promoter was fused to the 
luxABCDE cassette (PsigV-luxABCDE). E. faecalis V583 harboring pKS313 generated detectable light 
signal only in the presence of 1 mg/ml lysozyme while the pptAB deletion strain harboring pKS313 
failed to generate light signal even in the presence of lysozyme suggesting that SigV is 
constitutively inactivated in a pptAB deletion mutant (Fig. 5-1B). In 2008, Heinrich et al. showed 
that the deletion of the pptAB homolog (ecsAB in B. subtilis) resulted in the inactivation of the 
Site-2 protease RasP, which cleaves the anti-sigma factor RsiW and this in turn resulted in the 
constitutive inactivation of the ECF sigma factor SigW (21). The authors in this study were able 
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to partially complement the ecsAB deletion phenotypes by overexpressing RasP. We wanted to 
determine whether the overexpression of Eep in a pptAB deletion mutant would restore its 
lysozyme resistance to wild-type levels. The Eep complementation vector pSV24 (pEep)  (16) was 
electroporated into ΔpptAB and as a control V583 and ΔpptAB harboring the vector pKS12 (16)  
 
               
 
Figure 5-1: Deletion of pptAB results in increased lysozyme sensitivity. A) Lysozyme minimum inhibitory 
concentration (MIC) assay performed using the wild-type (V583), pptAB deletion mutant and the 
complement strain. B) Luciferase reporter assay was performed using V583(pKS313), ΔpptAB(pKS313) 
and ΔsigV(pKS313) in the presence (+) and absence (-) of 1 mg/ml lysozyme. RLU refers to relative light 
units. C) Complementation of ΔpptAB lysozyme defect using an eep complementation vector (pEep). As a 
control, V583 and ΔpptAB harboring the empty vector pKS12 were used. Plates with and without the 




backbone vector were also generated and these were spotted onto plates either containing 10 mg/ml 
lysozyme or no lysozyme. The results are shown in Figure 5-1C. The overexpression of eep in the 
pptAB deletion strain using the Eep complementation vector pEep (16) resulted in a modest 
complementation of the lysozyme sensitivity suggesting that the membrane activity of Eep might 
be compromised in a mutant strain lacking pptAB. Although the exact reason as to why SigV does 
not get activated in a pptAB mutant in the presence of lysozyme remains to be elucidated, it is 
possible that apart from its role in peptide pheromone secretion, PptAB might also be serving a 
more broader role of clearing the protein-based membrane debris present after protein processing 
in E. faecalis. Deletion of this transporter could result in the accumulation of peptide fragments 
that clog the membrane, resulting in the inability of membrane-embedded proteins (e.g. Eep) from 
functioning properly. Further studies are warranted to validate this hypothesis. 
In the dawn of post-antibiotic era it is important to identify important genes that are essential for 
the pathogenesis of multi-drug resistant bacteria like E. faecalis since these could serve as potential 
therapeutic targets. In this work we have identified distinct roles played by 3 different membrane 
proteins in the biology of E. faecalis. It is interesting to note that the membrane protein Eep has 
been shown to play an important role in the enterococcal rabbit model of endocarditis (22) and the 
enterococcal murine model of catheter associated urinary tract infection (23). It is possible that 
lysozyme sensitivity associated with an eep deletion mutant (16) contributes to this phenotype 
since lysozyme is considered as a critical innate immune component of the host. Further studies 
are warranted to determine the exact role played by this membrane protein in the pathogenesis of 
E. faecalis in a host. Most infections caused by E. faecalis are biofilm associated indicative of the 
importance of this lifestyle during host adaptation. Several factors have already been shown to be 
critical players in E. faecalis biofilm development. These include the Fsr quorum sensing system 
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(24), the proteases (GelE and SprE) regulated by the Fsr system (25), the alternate sigma factor – 
RpoN (26), the extracellular polysaccharide of E. faecalis – Epa (27) and the endocarditis and 
biofilm-associated pilus – Ebp (28). We have recently demonstrated the involvement of peptide 
pheromone transporters during biofilm formation in E. faecalis. Deletion of the peptide pheromone 
transporter (PptAB) and both the oligopeptide permease (Opp) complexes in tandem results in a 
biofilm defect suggestive of a possible role played by linear peptide pheromones in E. faecalis 
biofilm development.   
Peptide pheromones have been shown to play an important role in the biofilm development of 
several pathogenic microorganisms (24, 29, 30). In E. faecalis, the Fsr quorum sensing system 
results in the production of the cyclic peptide pheromone GBAP which in-turn regulates biofilm 
development by affecting the expression of the proteases GelE and SprE (31). However, the 
contribution of linear peptide pheromones (lipoprotein derived and genome encoded) in the 
regulation of E. faecalis biofilm development still remains to be elucidated. Recently, Chang et al.  
showed that two linear peptide pheromones (SHP2 and SHP3) regulate biofilm formation in S. 
pyogenes by interacting with the RNPP (Rap, NprR, PrgX, PlcR) family transcriptional regulators. 
Rgg2 and Rgg3 (32). The authors also showed that the processing of this peptide was Eep 
dependent and this peptide was imported back into the cell via an Opp complex. Taking into 
account the aforementioned similarities between the E. faecalis and S. pyogenes linear peptide 
pheromone signaling and the contribution of PptAB and Opp complexes in E. faecalis biofilm 
development (12), we hypothesized that biofilm formation in this bacterium could be regulated by 
RNPP family proteins. Bioinformatic analysis of the V583 genome resulted in the identification 
of several RNPP homologs amongst which 5 are chromosomally encoded (EF0073, EF1224, 
EF1316, EF1599 and ElrR (EF2687)) and 2 are encoded by the pheromone responsive plasmids, 
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pTEF1 and pTEF2, and closely resemble PrgX-like regulatory proteins (EFA0004 and EFB0005) 
(33). Ibrahim et al. in 2007 identified several short hydrophobic peptide encoding genes in E. 
faecalis strain V583 using bionformatic analysis and some of these genes are located adjacent to 
the genetic locus of the aforementioned RNPP family proteins (34).  To explore the possibility that 
one of these RNPP homologs plays a role biofilm formation, we decided to test whether EF0073 
plays a role in E. faecalis biofilm formation due to the significant sequence similarity and structural 
homology it shares with other RNPP family proteins (33).  
                                  
Figure 5-2: Deletion of ef0073 results in hyper biofilm formation. A) 96 well plate biofilm assay using the 
V583, Δef0073, and its single copy genomic integration (Δef0073::ef0073) and multiple copy plasmid 
(Δef0073(pEF0073)) complementation strains B) Scanning electron microscopy analysis of V583 and 




When we generated an ef0073 deletion mutant strain, it formed significantly more biofilms 
compared to the wild-type (Fig 5-2A) in a plate biofilm assay (see Appendix: Materials & 
Methods) and we were able to corroborate this observation using scanning electron microscopy 
(SEM) analysis wherein there was a significant difference between the biofilms formed by the 
wild-type and the mutant (see Appendix: Materials & Methods) (Fig 5-2B). This phenotype was 
complementable when a single copy of this gene was integrated back into the genome of the ef0073 
deletion strain at an ectopic locus (Fig 5-2A). However, when ef0073 was overexpressed in the 
mutant strain using a high copy plasmid, biofilm formation was attenuated significantly suggesting 
that EF0073 might be serving as a repressor of biofilm formation in E. faecalis. Since RNPP family 
proteins in other bacteria have been known to act as repressors (14), it is possible that EF0073 is 
one such protein.  The fact that two genes that potentially encode for peptide pheromones are 
located adjacent to ef0073 in the V583 genome further strengthens our hypothesis that EF0073 is 
potentially regulating biofilm formation by interacting with either of these peptides.   
SEM analysis of the V583Δef0073 biofilms also revealed the presence of an abundant exo-polymer 
matrix which was much less abundant in the wild-type V583 biofilms (Fig 5-2B). We hypothesized 
that EF0073 might be repressing the expression of genes that are involved in the synthesis of a 
major exo-polysaccharide and that the deletion of ef0073 results in the over production of this exo-
polymer matrix which in turn contributes to the hyper-biofilm phenotype. We wanted to determine 
whether EF0073 regulated the synthesis of the well characterized E. faecalis capsular 
polysaccharide (35) and a putative polysaccharide locus [EF_0883-EF_0891], which shares some 
sequence similarity with IcaA, part of the synthetic machinery for the intracellular adhesion 
polysaccharide found in S. aureus and S. epidermidis (36). We took advantage of a previously 
described capsular polysaccharide extraction/detection protocol (see Appendix: Materials & 
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Methods) (35) and extracted the exopolymer carbohydrate content of V583 and V583Δef0073. 
V583ΔcpsC was used as a negative control in this assay since it is known that this mutant is 
defective in synthesizing the capsular polysaccharide (35). We also layered the cpsC gene deletion 
in the V583Δef0073 strain background to generate V583Δef0073ΔcpsC and we analyzed the 
carbohydrate content of this double mutant to determine whether the deletion of ef0073 altered the 
synthetic pathway of the capsular polysaccharide. The cell wall carbohydrate  content of V583, 
V583Δef0073, V583ΔcpsC and V583Δef0073ΔcpsC were detected following electrophoresis on 
a PAGE gel with the cationic dye, Stains-All (3,3′-dimethyl-9-methyl-4,5,4′5′-
dibenzothiacarbocyanine). The results of this analysis are shown in figure 5-3. 
                                             
 
Figure 5-3: Detection of cell wall carbohydrate polymer species among V583, V583Δef0073, V583ΔcpsC 
and V583Δef0073ΔcpsC by electrophoresis through a 10% polyacrylamide gel with Stains-All detection 




Deletion of ef0073 did not affect the production of the capsular polysaccharide suggesting that 
EF0073 is not regulating the synthesis of the E. faecalis capsular polysaccharide.  When cpsC was 
deleted in V583Δef0073 strain, the resulting double mutant strain did not make any capsular 
polysaccharide suggesting that capsule production in V583Δef0073 was still dependent on the cps 
pathway. Since the deletion of the ica operon resulted in a severe biofilm defect in S. aureus (36), 
we wanted to determine whether the EF_0883-EF_0891 operon in E. faecalis contributed to the 
hyper-biofilm phenotype exhibited by V583Δef0073 . To assess this, we generated a deletion 
mutant in V583 and V583Δef0073 strain backgrounds and tested these mutants in a plate biofilm 
assay (see Appendix: Materials & Methods). The deletion of ef_0883-ef_0891 (Ica homolog) in 
V583 resulted in a severe biofilm defect suggestive of an important role played by this operon in 
E. faecalis biofilm formation. Biofilm formation by V583Δef0073Δica was also significantly 
reduced compared to V583Δef0073 indicative of a possible role played by this operon in the hyper-
biofilm phenotype exhibited by V583Δef0073.  Analysis of the promoter upstream of ef0883 that 
might possibly drive expression of the operon both in V583 and the ef0073 mutant, however, failed 
to reveal significant differences in promoter activity under normal growth conditions (data not 
shown).  Whether EF0073 contributes to the regulation of the ef_0883-ef_0891 (Ica homolog) 
operon under biofilm-specific conditions remains to be elucidated and will likely be a component 
of future study.  
Apart from causing persistent biofilm-associated infections like endocarditis and catheter 
associated urinary tract infections, E. faecalis also has the ability to disseminate a wide variety of 
antibiotic resistance genes not only amongst itself but to other pathogenic species including S. 
aureus. Studies have shown that clinical isolates of S. aureus obtained the vancomycin resistance 
genes via the conjugative transposon Tn1546 present in the co-infecting E. faecalis isolate (37, 
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38). This is attributed to the fact that S. aureus produces a pheromone, derived from a lipoprotein 
signal sequence that is known to mimic the enterococcal pheromone cAM373, enabling exchange 
of genetic information between these two species. Recently, a genetic determinant in 
Streptococcus gordonii encoding a predicted lipoprotein was also identified as a precursor for a 
peptide pheromone resembling cAM373, which enables intergeneric DNA transfer between E. 
faecalis and this dental pathogen (39).  
In this dissertation, we have identified genes encoding membrane proteins that have overlapping 
roles not only in E. faecalis stress adaptation and biofilm formation but also in the transfer of 
pheromone-responsive plasmids (conjugation) which often results in the dissemination of 
antibiotic resistance genes and even virulence traits (40). Eep and PptAB have overlapping roles 
not only in cell-cell communication but also in lysozyme stress adaptation (12, 16, 17). 
Considering the fact that both the proteins are predicted to be membrane embedded, it is possible 
that Eep and PptAB interact to form a complex. Further studies are warranted to determine the 
exact nature of this proposed interaction. It is also possible that Eep and PptAB along with Opp 
complexes might be important for enterococcal virulence in a host based on the roles they seem to 
be playing in biofilm development, lysozyme resistance and transfer of pheromone responsive 
plasmids. Testing mutants that lack eep, pptAB or the opp complexes in relevant vertebrate host 
models is warranted to determine whether these enterococcal membrane proteins contribute to 






Summary and Future Directions: 
 
Figure 5-4: A/B) Peptide pheromone mediated biofilm regulation in E. faecalis. C) Activation of the 
extracytoplasmic function sigma factor, SigV, via the regulated intramembrane proteolysis pathway. D) 
“Vacuum cleaner model” hypothesis. 
 
In this dissertation, we have identified the transporters that are essential for the import and export 
of lipoprotein derived peptide sex pheromones in E. faecalis. We have shown that the deletion of 
these peptide transporters results in a biofilm defect which is indicative of a role played by peptide 
signaling in regulation of biofilm development (12) (Varahan et al., Submitted-Journal of 
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Bacteriology). A possible mechanism by which peptide pheromones could regulate biofilm 
formation in E. faecalis is depicted in figure 5-4A-B. 
RNPP family protein mediated biofilm regulation (Fig 5-4A). 1) Lipoprotein-derived peptide 
pheromones and/or peptides derived from putative short coding sequences (34) are exported via 
the Peptide Pheromone Transporter (PptAB) (41).  2) Secreted peptides are bound by OppA or its 
homologs with high affinity 3) and actively imported into the cell via either of the oligopeptide 
permease complexes 4) where the peptide(s) interact with plasmid or chromosomally encoded 
RNPP family members in E. faecalis to regulate the expression of biofilm important genes. 
Pheromone-responsive plasmid mediated biofilm regulation (Fig 5-4B). 1) Peptide pheromones 
produced by recipient E. faecalis populations are sensed by the OppA homologs (PrgZ/TraC) 
encoded by the cognate pheromone-responsive plasmids and are imported into the donor cells via 
the chromosomally encoded oligopeptide permeases. 2) This alleviates the PrgX/TraA-mediated 
repression of conjugative functions resulting in activation of pheromone-responsive genes 3) with 
subsequent plasmid transfer to the recipient cells. 4) Aggregation substance, a pheromone-
responsive gene product, is also known to contribute to ex-vivo biofilms (42) and endocarditis 
(43).  
Identifying the specific RNPP family involved in the regulation of biofilm formation is warranted 
as this will provide a mechanism by which biofilm formation is regulated by peptide signaling. To 
elucidate the role played by pheromone-responsive plasmids (pTEF1 and pTEF2) in the virulence 
of E. faecalis V583, strain V19 which is V583 devoid of all its pheromone-responsive plasmids 
(pTEF1 and pTEF2) should be tested in relevant vertebrate host models along with V583 to 
determine the overall contribution that these plasmids play in enterococcal pathogenesis. 
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We also show that the deletion of the peptide pheromone transporter (PptAB) results in 10-fold 
reduction in lysozyme resistance compared to V583 (Fig 5-1A). Lysozyme resistance in E. faecalis 
is regulated by an extracytoplasmic function sigma factor called SigV which is activated only in 
the presence of lysozyme via regulated intramembrane proteolysis (Fig 5-4C). 1) E. faecalis 
perceives a stress signal, which in this case is lysozyme. 2) This leads to the cleavage of RsiV by 
the putative site-1 protease.  Based on data from reference (44), E. faecalis and other gram-
positives such as B. subtilis possess an additional putative trimming protease activity that prepares 
the processed RsiV for further proteolytic targeting by Eep  3) Eep degrades the site-1 protease 
processed and trimmed RsiV, leading to the release of SigV into the cytoplasm. 4) ClpXP or related 
cytoplasmic proteases further degrade RsiV to release active SigV. 5) SigV initiates the binding 
of the RNA polymerase upstream of specific genes that confer lysozyme resistance. 6) As 
membrane proteins, Eep and PptAB might be forming a complex and the deletion of pptAB might 
affect the proper functioning of Eep and this could explain the lysozyme resistance defect exhibited 
by a pptAB mutant.  
Another interesting possibility is that PptAB serves as a “vacuum cleaner” clearing peptide debris 
from the membrane of E. faecalis and that the deletion of pptAB might result in the accumulation 
of lipoprotein derived peptide sex pheromones and possibly other peptide debris and this might 
interfere with the intramembrane active site of Eep resulting in the lack of activation of SigV under 
lysozyme stress (Fig 5-4D). We hypothesized that cells lacking PptAB would possess a wider cell 
membrane compared to wild-type V583 due to the accumulation of peptide pheromones and other 
peptide debris. We performed transmission electron microscopy (TEM) analysis to visualize the 
cell membrane of V583 and V583ΔpptAB and the results are shown below (Fig 5-5). The 
membrane thickness of V583ΔpptAB was significantly higher than that of the wild-type suggesting 
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that V583ΔpptAB might be accumulating more peptide debris compared to wild-type V583. 
Further studies are warranted to confirm this hypothesis. 
 
                                
Figure 5-5: A) TEM analysis looking at the cell membranes of V583 and V583ΔpptAB. Black arrow 
indicates a region of V583ΔpptAB that appears to significantly wider that V583. B) Quantification of 
membrane thickness using Image J. Membrane width was measured in nanometers (nm) (see Appendix: 
Materials & Methods).  
 
There is a growing appreciation for the roles played by linear peptide pheromones in the biology 
of several clinically relevant gram-positive pathogens. Opp complexes, Eep and PptAB are broadly 
conserved amongst all pathogenic Firmicutes and novel therapeutics that inhibit the normal 
functioning of these proteins in E. faecalis could very well serve as potent anti-infectives against 
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E. faecalis as well as other pathogenic bacteria. In the growing era of antibiotic resistance and the 
lack of industrial commitment to the discovery of new treatment options for drug-resistant 
infections, it is paramount that we focus efforts on the discovery of new paradigms for treating 
bacterial infections.  One such strategy would be to target the aforementioned proteins (Eep, 
PptAB and the Opp complexes) to discover novel compounds that block their function and thus 
block dissemination of drug-resistance, prevent biofilm development and dampen the organism’s 
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MATERIALS AND METHODS: 
Plate Biofilm Assay: 
Biofilm formation on polystyrene was quantified with the crystal violet staining method as 
previously described (1). Each assay was performed in pentaplicates and repeated twice. All the 
strains tested in the plate biofilm assay were grown overnight in tryptic soy broth (TSB) at 37°C. 
V583Δef0073 (pEF0073) was grown in TSB with spectinomycin at a concentration of 500 µg/ml 
for maintenance of complementation plasmid. These cultures were back diluted (1:100) in fresh 
TSB and seeded into the 96-well plate and were incubated at 37°C for 24 hours. Biofilms were 
quantified by crystal violet staining after these 24hr biofilms were thoroughly washed with 
phosphate buffered saline (pH 7.4) to remove planktonic bacteria.  
Scanning Electron Microscopy:   
V583 and V583Δef0073 biofilms were grown for 24 hrs in glass coverslips using tryptic soy broth 
(TSB) at 37°C. Biofilms were immersion fixed in a fixative containing 2% paraformaldehyde and 
2% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2-7.4) for 1-2 hrs at 4°C. The fixative 
completely immersed the entire biofilm. V583 and V583Δef0073 biofilms were then gently wash 
3 x 5 minutes using distilled water. Cover slips containing the biofilms were dried under a vacuum 
of approximately 10-3torr for 1hr prior to mounting on aluminum stubs with carbon adhesive tape. 
Biofilms were imaged in a Nova NanoSEM 430 (FEI Company) using a low voltage high contrast 
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backscatter detector (vCD) under high vacuum using beam deceleration with an incident beam of 
4.69kV and a landing energy of 750V. 
Purification and Characterization of Capsular Polysaccharide: 
E. faecalis strains V583, V583Δef0073, V583ΔcpsC and V583Δef0073ΔcpsC were grown at 37°C 
without aeration overnight Todd–Hewitt broth supplemented with 1.0% glucose. For purification 
of cell wall polysaccharides, the method of Hancock et al. (2) was used. After enzymatic digestion 
of the enterococcal cell wall, carbohydrates were precipitated by the addition of ethanol to a final 
concentration of 75%. The precipitable material was collected by centrifugation (22,000 × g, 20 
min), washed with 75% ethanol, air-dried, and redissolved in 50 mM Tris⋅HCl (pH 8.0), 150 mM 
NaCl. Samples were analyzed by electrophoresis through 10% polyacrylamide (33:1) in Tris-
borate buffer (0.2 M Tris-base/0.2 M boric acid/20 mM EDTA, pH 8.3), with detection of 
polysaccharides using the cationic dye Stains-All (3,3′-dimethyl-9-methyl-4,5,4′5′-
dibenzothiacarbocyanine). Gels were stained for a minimum of 6 h in the dark and destained in 
distilled water before photography. 
Transmission Electron Microscopy:   
E. faecalis strains V583 andV583ΔpptAB were grown as 10ml cultures at 37°C without aeration 
overnight Todd–Hewitt broth. Cells were centrifuged and the pellets were fixed in 1ml of fixative 
solution containing 2% paraformaldehyde and 2% glutaraldehyde in 0.1 M sodium cacodylate 
buffer 7.2-7.4 for 16 hrs at 4°C with constant rotation. Samples were washed 3 times for 5 minutes 
in 1ml of 0.1 M sodium cacodylate buffer 7.2-7.4 at room temperature with constant rotation. 
Samples were fixed with 1-2% (Initial culture volume) osmium tetroxide in 0.1 M sodium 
cacodylate buffer 7.2-7.4 at room temperature with constant rotation for 2 hrs. Samples were 
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washed again 3 times for 5 minutes in 1ml of 0.1 M sodium cacodylate buffer 7.2-7.4 at room 
temperature with constant rotation. Samples were dehydrated using a series of acetone washes 
(washed 3 times for 5 minutes with 1ml acetone) with ascending concentrations of acetone (50%, 
60%, 70%, 80%, 90%, 95% and 100%) at room temperature. The tubes were wrapped in silver 
foil to protect from light. Following the dehydration using acetone, samples were infiltrated with 
EMBED 812/Araldite resin at room temperature for 24-48 hrs. Finally, the resin containing the 
samples were polymerized by drying it in an oven at 60°C for 24-48 hrs. Cross sections of the 
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